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Dit proefschrift richt zich op thermoregulatie tijdens hardlopen. Na het 
behandelen van de algemene principes van thermoregulatie tijdens inspanning 
wordt onderzocht hoe vaak hyperthermie (een kerntemperatuur hoger dan 
40°C) voorkomt na het lopen van een 15-km hardloopwedstrijd. Tevens worden 
factoren geïdenti ceerd die signi cant kunnen voorspellen in hoeverre de 
kerntemperatuur tijdens inspanning zal stijgen. In de opvolgende hoofdstukken 
wordt de rol onderzocht van afzonderlijke systemen die invloed hebben op, 
of beïnvloed worden door de kerntemperatuur tijdens inspanning. Allereerst 
wordt onderzocht in hoeverre pro-in ammatoire cytokines welke aangrijpen 
op het hypothalame temperatuursetpoint een rol spelen in de stijging van de 
kerntemperatuur tijdens inspanning. Voorts wordt in een beschrijvende pilotstudie 
onderzocht of elite rolstoeltennis atleten met een dwarslaesie een grotere kans 
hebben op warmte-gerelateerde gezondheidsproblemen vergeleken met elite 
rolstoeltennis atleten zonder dwarslaesie. Als laatste worden de potentiële 
e ecten van een verhoogde kerntemperatuur op het stollingssysteem beschreven.
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G eneral  Concepts  of  Human Thermoregulat ion
Being the world’s most sophisticated piece of machinery, the human body is able to 
sustain itself nearly fully automatically with very little need for conscious effort such 
as gathering food or taking shelter from extreme weather conditions. It self-regulates 
respiration, circulation, removal of (toxic) waste products and maintains the optimal core 
body temperature for all these processes. The temperature at which all cell processes are 
performed optimally lies between 36.0 – 37.5°C.1-4 Within this temperature range proteins 
fold into their optimal molecular shape at which enzymatic reactions are best catalysed.5-7 
Since core body temperature plays a key-role in all bodily processes, it is strictly maintained 
within this optimal range.2-4 7
In terms of temperature, the body can be divided into two main compartments: 1) the 
core, constituting the cerebral, thoracic and abdominal area, and 2) the shell, constituting 
the region outside of the core including the extremities and the skin (Figure 1-1).4 8 The 
actual core body temperature is measured by the body at different locations: the core body 
temperature is measured centrally in the pre-optic area of the hypothalamus and possibly 
also in the spinal cord, and shell temperature peripherally through skin thermosensors.4 8-10 
The central thermosensors are the primary sensory afferents for core body temperature, 
and are most sensitive to normal and elevated temperatures. The peripheral temperature 
sensors are most sensitive to lower temperatures and give rise to early heat-conserving 
responses for example in case of cold weather conditions, even before any drop in core 
body temperature is observed.2 8 11 The afferent signals of both the core and the shell 
are integrated in the body’s thermoregulatory centre, located in the hypothalamus.4 10 
This thermostat continuously compares the measured core body temperature with the 
hypothalamic setpoint, typically lying between 36.0 – 37.5°C in healthy subjects.2-4
If the body temperature deviates too much from the hypothalamic setpoint, central and 
peripheral effector mechanisms are activated to either conserve and produce heat or to 
dissipate excess body heat to the outside world.2 4 In essence, a cold environment will 
first be sensed by the body’s peripheral thermosensors located in the skin, and induce 
vasoconstriction of peripheral arterioles which restricts the flow of warm blood to the shell 
well before any drop in core temperature is noticeable. Other mechanisms to prevent the 
core temperature from dropping are based on increased heat production due to muscle 
activity (increased physical activity pattern, shivering), and heat generation in brown 
adipose tissue.4 12-14 Conversely, even the slightest increase in body temperature will be 
sensed in the preoptic area of the hypothalamus and will induce powerful heat dissipating 
responses.4 10 One of the primary heat dissipating mechanisms of the body constitutes 
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peripheral vasodilatation, increasing the flow of heated blood from the core to the shell, 
allowing increased heat loss to the outside world.2 4 8 15 16 However, the most important 
heat-releasing method is the evaporation of sweat from the skin, which extracts 58 kcal 
of heat per 100mL of evaporated sweat. Lastly, a semi-autonomic mechanism to either 
conserve or even gain heat, or maximize the gradient between the shell temperature to 
the outside world, are behavioural adjustments.18-20 Examples are the instinct to either 
get out of the cold or to look for shade, to reduce the physical activity level, or to add or 
reduce extra layers of clothing.
Figure 1-1:	 Schematic	 overview	 of	 human	 temperature	 distribution.	 The	 dark	 area	 represents	 core	 body	
temperature,	the	light	area	represents	the	body	shell.	(A)	Represents	a	euthermic	state,	(B)	shows	a	situation	
where	core	body	temperature	rises	and	heat	from	the	core	is	distributed	to	the	periphery	in	order	to	expedite	
heat	loss	in	the	shell.	(C)	Represents	a	hyperthermic	state	where	even	the	shell	warms	up	to	accommodate	heat	
loss	from	the	shell	even	further.	Adapted	from	Hart	et	al.	17
Chapter 110   |
Exercise:  A  Burden in  Thermoregulat ion
A common cause for body temperature to be elevated is physical exercise. Muscle labour is 
generally very inefficient, producing approximately 20% kinetic energy and the remaining 
80% of the total energy use is generated as heat.8 21 With the thermoregulatory setpoint 
unaltered at 36.0 – 37.5°C, the rising core body temperature will induce heat dissipating 
mechanisms in order to maintain the core temperature as close to the normal levels as 
possible.4 8 16 However, the increased metabolic heat production due to muscle activity 
will often surpass the body’s heat dissipating capacity and core body temperature will rise 
as a result.22 23 In fact, were no heat-dissipating mechanisms present, it is estimated that 
core body temperature would rise 1°C during every 5 minutes of exercise.22 Several factors 
have been identified to influence body temperature during exercise, and can be divided 
into external factors and internal factors.
As external factors, environmental conditions play a paramount role in thermoregulation.4 
16 22 Since the body is subject to direct heat transfer between skin and air, a high ambient 
temperature increases heat load and results in a higher body temperature. Furthermore, 
with sweating being the body’s principal heat dissipating mechanism, a high humidity 
negatively impacts on the speed of sweat evaporation and therefore also increases heat 
load. Lastly, a strong heat radiation (e.g. direct strong sunlight) can warm up the skin and 
impair heat dissipation.
In essence the human thermoregulatory system can be visualised according to the 
following schematic shown in Figure 1-2.
In addition, numerous internal factors are known to influence thermoregulation during 
exercise. For instance, high exercise intensity exercise such as running, cycling or dynamic 
sports such as football or rugby will cause a high metabolic rate. The consequential strongly 
increased metabolic heat production is known to increase the risk of heat illness.24 25 Other 
thermoregulatory burdens are dehydration and low fluid intake prior to the exercise bout, 
as the reduced sweat rate lowers the body’s capacity to dissipate heat by evaporation.1 22 26 
Male sex,27 poor training,28 advanced age26 and a high body mass index22 26 28 have all been 
reported to pose increased demand on the thermoregulatory system and hence increase 
the risk of heat-related problems such as heat exhaustion or heatstroke.
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Figure 1-2: Overview	 of	 human	 thermoregulation.	 Core	 body	 temperature	 is	 measured	 centrally	 in	 the	
preoptic	 area	 neurons	 and	 processed	 in	 the	 thermoregulatory	 centre	 located	 in	 the	 hypothalamus.	 The	
thermoregulatory	centre	compares	the	body’s	measured	core	body	temperature	to	the	hypothalamic	setpoint,	
and	 uses	 diff	erent	 eff	ector	 mechanisms	 to	 either	 increase	 core	 body	 temperature	 or	 lower	 it.	 This	 includes	
neurological	 eff	ector	 mechanisms	 to	 the	 shell	 as	 well	 as	 behavioural	 mechanisms	 in	 the	 form	 of	 physical	
exercise.	Adapted	from	Dr.	P.	Vis:	Lecture	Thermodynamics
Rising Core Body Temperature: A Burden for Performance and Wellbeing
Whilst an increased core body temperature seems to be a normal physiological 
phenomenon during exercise, excessive rises can have a deleterious effect on the 
individual’s wellbeing. A commonly observed problem in the heat is heat syncope. This is 
essentially caused by venous pooling of blood and vasodilatation in the skin, resulting in 
self-limiting syncope due to orthostatic hypotension.22 27 29  A second commonly observed 
problem is heat exhaustion, causing symptoms including malaise, dizziness, nausea and 
headache. Heat exhaustion is thought to be caused by fluid and sodium deficiencies and 
precedes the onset of more serious heat-related problems if the individual is to continue 
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exercise.22 27 30 Importantly, both heat syncope and heat exhaustion occur at core body 
temperatures <40.0°C, i.e. at relatively mildly elevated core body temperatures.
However, when thermoregulatory measures completely fail and core body temperature 
rises to values ≥40.0°C, exertional hyperthermia occurs.22 31 Whilst exertional hyperthermia 
can exist on its own and may remain fully asymptomatic, it has been described to 
potentially have more profound health implications. The most extreme consequence of 
prolonged hyperthermia is heatstroke, which is defined as hyperthermia combined with 
neurological deficits such as confusion, convulsions or coma.26 30 32 33 Whilst the exact 
aetiology of heatstroke is still unclear, it is thought to be based on an increased intestinal 
cell permeability which releases intestinal toxins into the circulation (endotoxaemia),34 
inducing an acute phase response with increased pro-inflammatory cytokine release (e.g. 
interleukin-1, interleukin-6).10 30 35-38 In addition, this disease state induces prothrombotic 
changes that ultimately leads to diffuse intravascular coagulation, multi-organ failure, and 
ultimately death.30 39-41 Whilst heatstroke is an extreme consequence of increased heat 
stress and increased body temperature, this disease state shows the profound derailment 
of several major body functions and demonstrates the importance of maintaining a 
normal body temperature at all times.
In addition to potentially endangering the individual’s health, exertional hyperthermia has 
also been shown to potentially result in a decreased exercise performance.42 The aetiology 
of hyperthermia-induced fatigue is thought to be related to several factors. First, several 
central (neurological) mechanism for fatigue has been suggested either as a result from the 
release of inflammatory cytokines or as a direct result of increased intracranial temperature. 
Both mechanisms induce a state of ‘central fatigue’ where motor neurons are innervated 
at a lower level than possible.42-44 The postulated aim of this mechanism is an attenuated 
metabolic heat production resulting in a self-limiting exercise-induced thermogenesis, 
protecting the individual from heating up too much. The other mechanism causing 
hyperthermia-induced performance decrease is related to cardiovascular limitations, 
where the increased muscle blood flow and fluid and electrolyte losses result in a reduced 
stroke volume and lowered cardiac output.15 21 23 Since blood volume depletion caused by 
sweating plays a prominent role in this mechanism, the medical and sports communities 
have produced detailed consensus statements underlining the importance of remaining 
adequate hydration at all times.45-50
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Spinal Cord Injury: A Disruption in Thermoregulation
The nervous system plays an essential role in human thermoregulation, and can be 
divided into the efferent (or effector) system, and the afferent (or sensory) system. The 
earliest convincing evidence to show that sympathetic innervation results in cutaneous 
vasodilation or vasoconstriction was brought by Grant and Holling in 1938.51 Effectively, they 
demonstrated that sympathetic ganglionectomy or nerve blockade on the sympathetic 
nerve fibres resulted in the inability to vasodilate when extremities were subjected 
to heat. Later research further detailed the importance of the sympathetic nervous 
system in thermoregulatory vasomotor function, including vasoconstriction during cold 
exposure.11 52 Similarly, the nervous system also essentially induces cutaneous sweating 
to dissipate even more heat when needed.9 Conversely, peripheral thermosensors submit 
their information to the central nervous system – specifically the hypothalamus – through 
the sensory afferents in the spinal cord.9 53
In spinal cord injured individuals, the interrupted neural connection prevents individuals to 
vasodilate or sweat below the level of the lesion, making them prone to thermoregulatory 
imbalance and heat problems.9 53 The higher the spinal cord lesion, the greater the body 
surface area that is unable to elicit thermoregulatory responses.53 54 Spinal cord injured 
individuals might therefore be at increased risk of developing heat problems during 
exercise, and can be considered a risk group.
Fever: A Physiological Deviation in Thermoregulation
The only exception when the body’s temperature setpoint deviates from its normal 
value of 36.0-37.5°C is fever. During fever, the sight of infection causes the release of a 
multitude of inflammatory cytokines such as interleukin-1 and interleukin-6.55-58 In turn, 
these cytokines stimulate the production of prostaglandins, thromboxane, leukotrienes 
and other acute phase proteins such as C-reactive protein, which all have their own 
specialized role in preparing the tissue for an immune reaction, attracting leukocytes, 
lymphocytes, inducing coagulation and starting tissue repair.59 60 One of these substances, 
prostaglandin E
2
, which is partly formed in the hypothalamus, increases the hypothalamic 
temperature setpoint and steers the body into elevating its temperature to temperatures 
up to ~41°C.56 61 The higher temperature during fever helps certain enzyme reactions run 
faster than is normally the case, improving the immune response and thus improving the 
chance of survival.62 63
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O utl ine of  Thesis
This thesis explores thermoregulatory responses of athletes during exercise and aims to 
identify which factors influence the magnitude of the increases in core body temperature. 
In addition, this thesis aims to gain further knowledge in the mechanisms responsible for 
the development of hyperthermia, and to assess its effects on haemostasis.
Chapter 2 aims to assess what core body temperatures are commonly observed after a 
15-km road race and assesses the incidence of exertional hyperthermia after the exercise 
bout. A second aim of chapter 2 is to identify factors that significantly predict the rise in 
core body temperature during the exercise bout, and develop a general model to show 
which factors induce a higher core body temperature. Core body temperature is measured 
before the start of the race and immediately after finishing.
Chapter 3 aims to further elucidate to which extent individual thermoregulatory responses 
can be used to better predict an individual’s core body temperature rise during exercise. 
To that end, thermoregulatory data from the same individuals who participated in two 
consecutive editions of a 15-km road race are correlated to each other. In addition, the 
predictive model devised in Chapter 2 is expanded by supplementing it with the historical 
data of the first race edition to test if it can be used to better predict core body temperature 
responses in the second race edition.
Chapter 4 is aimed at identifying the role of the thermoregulatory setpoint during exercise. 
Previous literature suggests that exercise causes the release of several pro-inflammatory 
cytokines. In theory, these cytokines might stimulate the production of prostaglandin E
2
 
in the hypothalamus, which then increases the thermoregulatory setpoint. Whether an 
increased setpoint, and thus decreased thermoregulatory responses leading to a higher 
core body temperature during exercise exist, is still unknown. Therefore, this chapter 
examines subjects performing submaximal treadmill exercise and measures core body 
temperature whilst the production of prostaglandin E
2
 is blocked. The hypothesis is that 
blocking prostaglandin E
2
 production will result in a lower core body temperature during 
exercise compared to a control condition.
Chapter 5 is aimed at comparing the thermoregulatory responses in wheelchair tennis 
players with and without a spinal cord injury during an outdoor tennis match. Spinal 
cord injured athletes have been shown to be at increased risk of developing heat related 
problems, since they are unable to elicit thermoregulatory responses below the level of the 
injury. However, previous studies were predominantly performed under well controlled 
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laboratory conditions. As such, the thermoregulatory strain of wheelchair tennis players 
is currently unknown, in spite of many tennis tournaments being organized in hot and 
humid ambient conditions. This pilot study measures changes in core body temperature 
and skin temperature in a small group of elite international-level wheelchair tennis players 
with and without a spinal cord injury to compare responses across both groups.
Chapter 6 focuses on the potential effects of core body temperature on haemostasis. 
Literature involving research on both hypo- and hyperthermia suggests that temperature 
directly influences the activity coagulation proteins. To what extent an exercise-induced 
rise in core body temperature in asymptomatic subjects impacts on the activity of 
haemostasis has not been well described. Therefore, chapter 6 is aimed at investigating 
whether an increased core body temperature during exercise induces prothrombotic 
changes. Furthermore, since haemostasis assays are routinely performed at a temperature 
of 37°C, whilst the in vivo temperature of the targeted population is expected to be higher, 
the assay results might not provide accurate information. A subgroup of subjects will 
therefore undergo further analyses in which the assay temperature will be corrected for 
the subjects’ core body temperature during blood collection, to test whether adjusting 
the assay temperature provides more reliable information on haemostasis activity during 
exercise.
Chapter 7 provides a detailed general discussion on the main findings of the present 
thesis. The chapter closes with a future perspective and clinical implications of the main 
findings.
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Abstrac t
Objectives: Current knowledge about the incidence and risk factors for exertional 
hyperthermia (core body temperature ≥40°C) is predominantly based on military 
populations or small-sized studies in athletes. We assessed the incidence of exertional 
hyperthermia in 227 participants of a 15-km running race, and identified predictors for 
exertional hyperthermia.
Design: Observational study.
Methods: We measured intestinal core body temperature before and immediately after 
the race. To identify predictive factors of maximum core body temperature, we entered 
sex, age, BMI, post-finish dehydration, number of training weeks, fluid intake before and 
during the race, finish time, and core body temperature change during warming-up into 
a backward linear regression analysis. Additionally, two subgroups of hyperthermic and 
non-hyperthermic participants were compared.
Results: In a WBGT of 11°C, core body temperature increased from 37.6±0.4°C at baseline 
to 37.8±0.4°C after warming-up, and 39.2±0.7°C at the finish. A total of 15% of all 
participants had exertional hyperthermia at the finish. Age, BMI, fluid intake before the 
race and the core body temperature change during warming-up significantly predicted 
maximal core body temperature (p<0.001). Participants with hyperthermia at the finish 
line had a significantly greater core body temperature rise (p<0.01) during the warming-
up compared to non-hyperthermic peers, but similar race speeds (p=0.34).
Conclusion: 15% of the recreational runners developed exertional hyperthermia, whilst 
core body temperature change during the warming-up was identified as strongest 
predictor for core body temperature at the finish. This study emphasizes that exertional 
hyperthermia is a common phenomenon in recreational athletes, and can be partially 
predicted.
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I ntroduc tion
Current knowledge about the incidence and risk factors for exertional hyperthermia (core 
body temperature (CBT) ≥40°C) and heat illness is largely based on retrospective studies 
investigating military populations during military exercises.1-5 These studies involved well-
trained soldiers performing continuous exercise (e.g. long-distance running) superimposed 
by bouts of high-intensity anaerobic exercise (e.g. heavy lifting). This type of exercise is 
substantially different from a typical athletic event popular in the general public, during 
which the athletes typically only perform continuous high-intensity exercise. Furthermore, 
paramount to the general public is that it is characterized by a wide range of individual 
traits, including a wide diversity in body mass, age and training and health status.6 As 
all these factors may affect thermoregulatory responses differently, each individual may 
be subject to a different risk for developing heat-related problems, such as exertional 
hyperthermia or heat illness.4 5 7 Previous studies that did focus on thermoregulation in 
participants of athletic events or outdoor time trials in cool to moderate conditions are 
based on relatively small to moderate sample sizes.8-10 These studies reported exertional 
hyperthermia in 0-23% of their participants, mostly after performing marathon races, and 
this wide range makes it tenuous to draw any firm conclusions. In addition, no previous 
authors have confirmed whether this knowledge is applicable to the general public based 
on measurements in a large and heterogeneous sample size. Based on previous literature, 
risk factors for heat illness such as metabolic rate (i.e. running speed),8 11 12 dehydration at 
the finish line and low fluid intake before and during the race,13-15 increased body mass 
index,3 13 16 poor training,3 advanced age14 and male sex17 could significantly predict CBT 
at the finish line. However, it has never been confirmed whether these risk factors can be 
applied to identify athletes at risk of developing hyperthermia during large sports events.
Therefore, the main purpose of this study was to assess the CBT in a large (n=230) 
heterogeneous group of participants of a 15-km running race (Seven Hills Run, Nijmegen, 
the Netherlands). This race is one of the largest running events held in the Netherlands 
(>30.000 participants), and holds the men’s and women’s 15-km world records set in 2010 
and 2009 respectively. As a secondary purpose, we identified factors that significantly 
predicted CBT at the finish line using a backward linear regression analysis. The third aim 
was to assess the differences between athletes finishing with a high CBT versus those with 
a low CBT, in order to identify key features that may explain the CBT rise during exercise. To 
that end, we compared body and race characteristics in athletes with a finish CBT ≥40°C 
(hyperthermic athletes) to an equally sized group of athletes that finished with the lowest 
CBT of all participants (non-hyperthermic athletes).
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M ethods
Five-hundred participants of the Seven Hills Run were randomly contacted and, if 
interested, were sent a study protocol. All volunteers were screened for the presence of any 
exclusion criteria for using the temperature pill: 1. a history of obstructive or inflammatory 
bowel disease, or any prior abdominal surgery, 2. the presence of any implanted electric 
(medical) device, 3. a scheduled MRI scan within 1 week after the event, or 4. pregnancy. 
Two hundred-thirty participants were included in the study: 111 men and 116 women, 
were aged 45±11 years and had a BMI of 22.7±2.7 kg/m2 (Table 2-1). Study procedures 
were approved by the Radboud University Medical Centre Ethics Committee, accorded 
to the principles of the Declaration of Helsinki, and all participants provided written 
informed consent before participation.
Prior to the race, participants completed a questionnaire pertaining to their physical 
training. Participants self-reported their fluid intake from the time of getting out of 
bed on the day of the race and during the race. Body weight was measured before and 
after the race in a laboratory set up 50 meters from the finish line. CBT was measured at 
baseline in the laboratory about 2 hours before the start, 1 minute before the start (i.e. 
after warming-up), and within 15 seconds after finishing. Due to the large total number of 
participants in the race, runners started the race phased into in 9 separate ‘waves’ over a 
1 hour period. Ten research assistants measured CBT in 25±1 participants per wave using 
5 wireless receivers. Participants with a CBT ≥40°C upon finishing were compared to an 
equal number of participants that finished with the lowest CBT.
Participants ingested an individually calibrated telemetric temperature pill at least five 
hours (8 a.m.) before the race (start 1 p.m.) to prevent interaction of the CBT measurements 
with fluid ingestion during testing.18 CBT was measured using a portable telemetry system 
(CorTemp™ system, HQ Inc., Palmetto, USA). This measuring system has been demonstrated 
to safely and reliably measure CBT.19 20 The average of three consecutive measurements for 
each time point was used for further analyses. The change in CBT during warming-up was 
calculated by subtracting CBT at baseline from the CBT before the start of the race.
Body weight was measured to the nearest 0.1kg using an automatically calibrated balance 
(Seca 888; Hamburg, Germany) before and within 10 minutes after the race. The relative 
change in body weight was calculated and dehydration was defined as a body weight 
loss of ≥2%.21 Participants were allowed to drink ad libitum before and during the race, 
whilst they self-reported the time and amount (standard sized cups, bottles, etc.) of their 
individual fluid intake before and during the race. No restrictions were imposed on the 
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Table 2-1:	 Participant	 demographics,	 physical	 activity	 pattern,	 race	 characteristics,	 CBT,	 body	 weight,	 and	
ﬂ	uid	intake	in	the	total	group,	a	subgroup	of	hyperthermic	participants	at	the	fi	nish	line	and	a	subgroup	of	
non-hyperthermic	participants.
Total group Exertional 
Hyperthermia
Non-
hyperthermia
P-Value
Characteristics
Sex (male : female) 111:116 15 : 16 16 : 15 0.80
Age (years) 45 ± 11 43 ± 11 45 ± 11 0.49
Body mass index (kg/m2) 22.7 ± 2.7 23.0 ± 2.4 22.1 ± 2.6 0.17
Physical activity pattern
Number of previous participations 
in this event
5 ± 4 4 ± 3 5 ± 4 0.30
Training (weeks) 28 (range 0-52) 30 (range 3-52) 24 (range 0-52) 0.32
Running exercise (sessions/week) 2.5 ± 0.9 2.4 ± 0.8 2.7 ± 1.0 0.21
Race characteristics*
Split time 0-5 km (min) 26.2 ± 3.7 25.8 ± 3.0 25.4 ± 4.0 ANOVA (split times):
Split time 5-10 km (min) 26.4 ± 3.9 26.0 ± 3.1 25.5 ± 4.0 Time / Group / Time x Group
Split time 10-15 km (min) 26.6 ± 6.7 26.4 ± 3.5 25.3 ± 4.1 p=0.16 / p=0.46 / p=0.10
Total race time (min) 79.1 ± 12.8 78.3 ± 9.4 76.2 ± 11.9 0.46
Total race speed (km/h) 11.7 ± 1.8 11.7 ± 1.5 12.1 ± 1.9 0.34
Core Body Temperature
Baseline 37.6 ± 0.4 37.6 ± 0.4 37.4 ± 0.4 0.26
CBT change during warming-up 0.2 ± 0.5 0.5 ± 0.5 0.1 ± 0.4 <0.01
Start 37.8 ± 0.4 38.0 ± 0.5 37.5 ± 0.3 <0.001
Finish 39.2 ± 0.7 40.4 ± 0.4 38.1 ± 0.3 -
Body weight
Baseline body weight (kg) 71.7 ± 11.9 72.3 ± 11.4 70.0 ± 12.8 0.46
Finish body weight (kg) 70.8 ± 11.7 71.3 ± 11.6 69.0 ± 12.6 0.48
∆ Body weight (%) -1.5 ± 0.6 -1.7 ± 0.6 -1.5 ± 0.6 0.39
Classifying as dehydrated** (%) 21 29 24 0.67
Fluid intake
Fluid intake before race (L) 1.18 ± 0.47 1.0 ± 0.4 1.3 ± 0.5 <0.05
Fluid intake during race (L)
0.06 ± 0.12 0.04 ± 0.06 0.07 ± 0.13 0.24
* Differences in split times were tested using a Two-Way Repeated Measures ANOVA.
** Participants classified as ‘dehydrated’ if body weight at the finish line was reduced ≥2%.
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type of fluids consumed, though participants were requested to refrain from drinking 
between finishing and the second body weight measurement to avoid overestimating 
the post-race body weight. Furthermore, body weight change during the race (delta body 
weight) was corrected for fluid intake during the race by adding the fluid intake to the 
delta body weight.
Individual split times after 5-, 10- and 15-km were obtained from the organizational 
measuring system (ChampionChip®, MYLAPS, Nijmegen, the Netherlands).
Wet bulb globe temperature (WBGT) was measured every 30 minutes throughout the 
day using a portable climate monitoring device (Davis Instruments Inc., Hayward, U.S.A.) 
positioned in the start/finish area.
Statistical analyses were performed using the Statistical Package for the Social Sciences 
(IBM SPSS Statistics for Windows, Version 20.0. IBM Corp., Armonk, NY, USA). Data was 
reported as mean ± standard deviation unless otherwise indicated. A backward linear 
regression analysis was used to identify factors that significantly predicted finish CBT. 
Age, sex, BMI, finish time, fluid intake before and during the race, the presence of post-
finish dehydration, the delta CBT between baseline and the start and the number of 
training weeks were included as potential factors that could predict finish CBT. Differences 
between the subgroups of hyperthermic and non-hyperthermic participants were tested 
using a Student’s t-test for the continuous data, and a chi-square test for the nominal data 
(i.e. the presence of post-finish dehydration). The significance level was set at p≤0.05.
Results
The average race time was 79±13 min (range 55–165 min), with a mean running speed 
of 11.7±1.8 km/h (Table 2-1). Furthermore, the split times after every 5-km point were 
comparable (p=0.33) across the race. Under cool environmental conditions (WBGT was 
stable at 11°C throughout, T
DRY-BULB
 10.5°C, relative humidity 87%), CBT increased from 
37.6±0.4°C at baseline to 37.8±0.4°C after the warming-up at the start, and was 39.2±0.7°C 
upon finishing (Figure 2-1). CBT could not be measured at the finish line in 18 participants 
(8%). Thirty-one participants(15%) showed a CBT ≥40°C and were hence classified as 
being hyperthermic. None of the participants reported any apparent heat-related physical 
complaints.
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Figure 2-1: Frequency	distribution	of	core	body	temperature	(CBT)	at	baseline	(light	bars)	and	fi	nish	line	(dark	
bars).	Fifteen	percent	of	the	participants	had	exertional	hyperthermia	at	the	fi	nish	line	after	completion	of	the	
race.
Between baseline and finish, a 1.5±0.6% reduction in total body weight was observed, 
and 21% of all participants were classified as dehydrated (≥2% decrease in body weight). 
Self-reported fluid intake before the start of the race was 1.18±0.47L, whilst intake was 
0.06±0.12L during the race.
The backward linear regression model (r=0.41, p<0.001) identified age (B = -0.01, p=0.03), 
BMI (B=0.06, p<0.01), self-reported fluid intake before the race (B=-0.30, p=0.02) and CBT 
change during warming-up (β=0.56, p<0.001) as parameters that significantly predicted 
CBT at the finish line (Table 2-2). Sex, finish time, self-reported fluid intake during the race, 
the presence of post-finish dehydration and number of training weeks were also entered 
into the regression analysis, but did not appear to influence finish CBT. These results 
remained unchanged when the analysis was repeated after replacing the total finish time 
for the split time in the last 5-km.
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CBT change during warming-up was identified as the strongest predictor in our model. 
Accordingly, we were interested in the risk stratification of participants that demonstrated 
a CBT change during warming-up that was 2 times higher than the group average (0.2°C). 
Therefore, we created a new dichotomous variable in which participants were classified 
to a CBT rise ≤0.4°C or >0.4°C during warming-up. Exertional hyperthermia occurred 
significantly (p<0.001) more frequent in the participants with a CBT rise >0.4°C (33.3%) 
compared to participants with a CBT rise ≤0.4°C (9%) during warming-up (OR: 5.1, 95% 
CI: 2.2-11.7).
Two subgroups comprising 31 hyperthermic participants and 31 participants that 
finished with the lowest CBT of the total group (non-hyperthermic group) were selected 
for additional analyses with respect to body and race characteristics (Table 2-1). Within 
these groups, no differences were found for age, BMI, physical activity, race times, or 
body weight changes. The CBT change between baseline and the start of the race was 
significantly greater in the hyperthermic participants compared to the non-hyperthermic 
group (p<0.01). Furthermore, self-reported fluid intake before the race was significantly 
higher in the non-hyperthermic participants compared to the hyperthermic participants 
(p<0.05), whilst self-reported fluid intake during the race was similar in both groups.
Table 2-2: Predictors	for	finish	core	body	temperature.
Variable Univariate Analysis Multivariate Analysis*
B 95% CI β B 95% CI β
Constant 38.7 37.7 – 39.7
Age -0.01 -0.02 – -0.001 -0.19 C -0.01 -0.02 - -0.001 -0.16 C
BMI 0.07 -0.02 – 0.12 0.25 B 0.06 0.02 – 0.10 0.21 B
CBT rise after warming-up 0.54 0.30 – 0.78 0.33 A 0.56 0.33 – 0.80 0.35 A
Fluid intake before race -0.28 -0.52 - -0.03 -0.17 C -0.30 -0.53 - -0.06 -0.18 C
* R2 for model = 0.167; adjusted R2 = 0.147
A p <0.001; B p <0.01; C p <0.05; NS not significant
CI = confidence interval; β = standardized B
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Discussion
This study assessed the incidence of exertional hyperthermia in a large and heterogeneous 
group of athletes during a 15-km running event. We found that 15% of our participants 
passed the finish line with a CBT ≥40°C. Taking into consideration that approximately 
30.000 participants entered the race, this would mean that as many as 4.200 participants 
may have developed exertional hyperthermia. We found that age, BMI, CBT change 
during warming-up and self-reported fluid intake before the race predicted CBT at the 
finish line, whereas sex, self-reported fluid intake during the race, the presence of post-
finish dehydration, and the number of training weeks had no impact on finish CBT. 
Interestingly, we found no differences in body and race characteristics between the 
subgroups of hyperthermic athletes and their non-hyperthermic peers, apart from a 
higher (0.3L) fluid intake before the race by the non-hyperthermic athletes. However, the 
CBT change after the warming-up was significantly greater, and self-reported fluid intake 
before the race was significantly lower in the hyperthermic participants compared to the 
non-hyperthermic participants. Additionally, we found that athletes with a CBT rise after 
warming-up >0.4°C were significantly more likely (OR 5.1) to develop hyperthermia at the 
finish line. These results suggest that exertional hyperthermia is a common phenomenon 
in recreational athletes, does not necessarily result in physical complaints or a reduced 
exercise performance, and can be partially predicted.
To our knowledge, this is the first study to measure CBT at the finish line in a large and 
heterogeneous group of runners. We found that 15% of our participants developed a CBT 
≥40°C after 15-km running in cool conditions. Previous smaller-sized studies demonstrated 
that exertional hyperthermia occurs frequently during military exercises and athletic 
events,9 16 22 and our results are the first that confirm the relatively high incidence in a large 
sample-size from the general public. Interestingly, the reported incidence of hyperthermia 
in the present (15%) and previous studies (50% and 56%)9 22 seems to be higher than 
the reported CBT in several other studies (0%, 3% and 11%).10 11 23 The difference may 
relate to cooler conditions or longer exercise duration that was possibly performed at 
lower exercise intensity in the studies that found a smaller incidence. Another potential 
explanation might relate to the use of rectal probes in the three latter studies, which were 
inevitably inserted several minutes after finishing the race. As passive cooling may result 
in a CBT drop of 0.2-0.5°C within the first 5 minutes post-exercise,24 the studies measuring 
rectal temperatures may have in fact underestimated the actual CBT in their participants.
Despite the high incidence of exertional hyperthermia, none of our participants reported 
any apparent heat-related complaints. Furthermore, we found no differences in race times 
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between the subgroups with and without exertional hyperthermia, nor any differences in 
split times at the 5-, 10- and 15-km points (i.e. a stable running pace throughout the race). 
These results suggest that hyperthermia per se does not necessarily result in a reduced 
exercise performance. Previous authors have questioned the presence of a ‘critical’ CBT 
threshold for a reduced exercise performance,9 25 the latter of which is thought to be 
caused by a neurologically-mediated sustained decrease in muscle force production.26 
Based on a substantially larger sample-size, our results raise the same hesitations. 
Tolerance for hyperthermia is widely variable amongst athletes, but was demonstrated to 
be better in ambient conditions that favour low skin temperatures.9 25 27 The relatively cool 
environmental conditions in the present study may therefore at least partially explain why 
both the hyperthermic and non-hyperthermic participants were able to preserve their 
race times throughout the race. It would be of great interest to further explore this by 
assessing CBT and skin temperature in a large group of athletes during a similar running 
event under cool, moderate and hot environmental conditions, and investigate whether 
hyperthermia only leads to reduced performance levels when skin temperatures are high.
Interestingly, participants who showed a CBT rise >0.4°C between baseline and the 
start of the race (i.e. after warming-up) had a significantly higher occurrence (OR 5.1) 
of exertional hyperthermia upon finishing than participants who had a lower CBT rise 
during warming-up. Furthermore, the hyperthermic participants had a significantly 
greater CBT rise during the warming-up compared to their non-hyperthermic peers. 
This finding raises the question as to whether a strong CBT rise during warming-up can 
help in identifying athletes at risk of developing hyperthermia during the race. To our 
knowledge, no such relationship has been reported previously. However, it has been 
reported that a previous episode of heat illness predisposes athletes for a repeat event,13 
suggesting that an intrinsic predisposition for heat illness may exist. This hypothesis is 
reinforced by our finding that athletes with the strongest CBT rise after the warming-up 
were significantly more likely to become hyperthermic at the finish line, which suggests 
that a similar intrinsic predisposition for developing hyperthermia may exist as well. The 
clinical implication of this finding is that measuring the CBT rise during warming-up may 
aid in identifying individuals who should be monitored more carefully, and may help 
initiate a more direct treatment strategy if problems do occur (i.e. physical complaints or 
performance detriments). Furthermore, it might also help to identify individuals who are 
most likely to benefit from any pre-cooling interventions.
By measuring a large number of possible predictive factors for the finish CBT, we were able 
to predict 16.7% of the total finish CBT. The finding that a higher self-reported fluid intake 
before the race was predictive for a lower finish CBT in both the total group (regression 
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analysis) and in the non-hyperthermic subgroup versus the hyperthermic subgroup 
could relate to a difference in hydration status prior to the exercise bout. Since we did 
not measure the participants’ hydration status before the start of the race (e.g. through 
measuring urinary specific gravity at baseline), it is difficult draw any definitive conclusions 
about this. However, previous literature recommended that the consumption of ~0.4-0.5L 
of fluids 4 hours before the start of exercise ensures euhydration at the start of exercise.28 
Since the participants of the present study consumed 1.2±0.5L of fluids in the ~6 hour time 
span prior to the race, it is likely that they started the race in a euhydrated state. Apart from 
the potential role of fluid intake before the race, we found no other differences between 
both subgroups of hyperthermic and non-hyperthermic participants. This emphasizes the 
difficulty to predict CBT during exercise using traditional measures. Previous studies have 
shown that exercise intensity and physical fitness affect CBT during exercise.3 12 13 As our 
study was performed under race conditions, most participants performed in the upper 
range of their possible exercise intensity levels. This leaves only a small range of exercise 
intensities to correlate with CBT, and may explain why we did not find a significant 
relationship between both parameters.
The strengths of this study are the inclusion of a large and heterogeneous group of 
participants, the real-life race setting in which participants reach peak performances that 
cannot be simulated in a laboratory situation, and the fact that we measured CBT within 
seconds after finishing instead of several minutes after finishing. However, this study was 
limited by the fact that no correction was applied for sweat entrapment in the participants’ 
clothing after the race in regard to the body weight measurement after the race. Based on 
previous literature, it is known that not correcting for sweat entrapment in clothing may 
lead to a measurement error of 10%.8 As subjects in the present study had an average 
weight loss of -1.0±0.5 kg, actual sweat losses might have been underestimated by ~0.10 
kg on average. However, since the average change in body weight in the present study 
was already limited and remained below the recommended maximal weight change 
of 2%,21 we believe that this small underestimation did not substantially influence our 
conclusions.
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Conclusion
In cool environmental conditions (WBGT 11°C), 15% of the participants passed the 
finish line with exertional hyperthermia. The stable and similar race speeds in both the 
hyperthermic and non-hyperthermic participants suggest that hyperthermia per se does 
not necessarily result in performance detriments. The limited value of the predictors of the 
increase in CBT and the great similarities between both subgroups of hyperthermic and 
non-hyperthermic participants, emphasizes the difficulty to predict CBT during exercise. 
However, we did find that participants with a CBT rise after the warming-up >0.4°C were 
significantly more likely to develop hyperthermia at the finish line (OR 5.1), which may 
provide new prospects for predicting CBT and associated heat related problems during 
exercise.
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Abstrac t
Aim: To assess the within-subject variation of thermoregulatory responses during 
two consecutive 15-km road races. Secondly, we explored whether gastrointestinal 
temperature (T
GI
) data from the first race could improve our previously established 
predictive model for finish T
GI 
in the second race.
Methods: We measured T
GI 
before and immediately after both races in 58 participants, 
and determined correlation coefficients. Finish T
GI 
in the second race was predicted using 
a linear regression analysis including age, BMI, pre-race fluid intake, T
GI 
increase between 
baseline and the start of the race, and finish T
GI 
in the first race.
Results: Under cool conditions (WBGT 11-12°C), T
GI 
was comparable between both races at 
baseline (37.6±0.4°C vs. 37.9±0.4°C; p=0.24) and finish (39.4±0.6°C vs. 39.4±0.6°C; p=0.83). 
Finish T
GI 
correlated significantly between both races (r=0.50; p<0.001). The predictive 
model (p<0.001) could predict 32.2% of the finish T
GI 
in the second race (versus 17.1% 
without finish T
GI 
in race 1). 
Conclusion: Our findings demonstrate that the use of previously obtained 
thermoregulatory responses results in higher predictability of finish core body 
temperatures in future races, enabling better risk assessment for those athletes that are 
most likely to benefit from preventive measures.
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Introduc tion
An elevated core body temperature (CBT) is commonly observed in athletes performing 
exercise and does not typically affect health or performance.1 2 The CBT rise is caused by 
the production of metabolic heat in the exercising muscle, which cannot be completely 
released to the environment.3 If heat storage becomes uncompensable, athletes reduce 
their performance levels in anticipation of the ensuing CBT rise.4 Interestingly, the maximal 
CBT that individuals reach during outdoor time trials in cool to moderate conditions varies 
widely, ranging from 37.3-41.5°C.5-7 The variation in thermoregulatory responses has 
previously been linked to subject characteristics, (e.g. age, sex, exercise intensity, body 
weight, body mass index (BMI), muscle / fat mass 1 8-11) and external factors (e.g. ambient 
temperature, wind speed, humidity).1 5 12
Predicting exercise-induced CBT rises can help athletes to estimate their maximal CBT 
during race conditions. We demonstrated in a previous study that age, BMI, fluid intake 
before the race and the core body temperature change during warming-up are the 
primary predictors for maximal gastrointestinal temperature (T
GI
) in a 15-km road race 
under cool ambient conditions.7 Nevertheless, the combination of these within-subject 
and external parameters could only predict 16.7% of finish T
GI
. Previous studies revealed 
that a history of heat illness is an independent risk factor for a future repeated event.1 9 10 
These findings suggest that the magnitude of exercise-induced T
GI 
rises might be related 
to individually determined intrinsic factors. This would mean that, under exactly the same 
external conditions and with no changes in within-subject characteristics, one athlete 
would consistently demonstrate low CBT rises whereas another athlete will consistently 
demonstrate small CBT changes upon repeated equal bouts of exercise. Whether such 
consistent within individual thermoregulatory responses exist in the athletic populations, 
is currently unknown.
Therefore, the aim of this study was to assess the within-subject variation of 
thermoregulatory responses during two consecutive equal exercise bouts. Secondly, 
we explored whether including T
GI 
data from the first race edition could improve the 
predictability if the thermoregulatory responses during the second race edition. For 
these purposes, we performed T
GI 
measurements in 58 participants of a 15-km running 
event during two consecutive race editions, which were held under similar environmental 
conditions. We hypothesized that T
GI 
would strongly correlate between both exercise 
bouts and could improve the prediction of finish T
GI 
in a subsequent race.
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M ethods
We recruited 58 individuals (Table 3-1) that participated in two consecutive editions of 
a 15-km running event (Seven Hills Run, Nijmegen, the Netherlands; organized ~1 year 
apart). Before being included in the study, all subjects provided a written informed consent 
and all subjects were screened for the presence of any exclusion criteria for using the 
temperature capsule: 1. A history of obstructive or inflammatory bowel disease or prior 
abdominal surgery, 2. The presence of any implanted electric device, 3. A scheduled MRI 
scan within 1 week after the event, or 4. Pregnancy. Study procedures were approved by 
the Radboud University Medical Centre Ethics Committee and accorded to the principles 
of the Declaration of Helsinki. This study was conducted in agreement with the ethical 
standards according to Harriss et al.13
Table 3-1: Subject	characteristics	in	both	race	editions.
Variable Race Edition 1 Race Edition 2 P-Value
Sex (male : female) 31 : 28 -
Age (years)# 47 ± 10 -
Height (cm) 175 ± 8 -
Weight (kg) 73.0 ± 12.4 73.0 ± 12.3 0.71*
Body mass index (kg/m2) 23.6 ± 2.7 23.7 ± 2.8 0.75
Body Surface Area (m2) 1.88 ± 0.19 1.88 ± 0.19 1.00
# Age during race edition 1 is reported.
* P-value refers to a Wilcoxon Signed Rank test.
Study procedures and measurements were identical in both race editions. Baseline 
measurements were performed 2 hours before the start of the race in a laboratory set 
up 50 meters from the finish line. T
GI 
was measured at baseline, 1 minute before the start 
(i.e. after warming-up), and within 15 seconds after finishing. No measurements were 
performed during exercise, and subjects were allowed to complete the race at a self-
selected pace with ad libitum fluid intake.
Body height and weight (Seca 888 calibrated scale; Hamburg, Germany) were measured at 
baseline. Body mass index (BMI) and body surface area were calculated using the height 
and weight data. Body-surface area was calculated using the formula of DuBois et al.14
Subjects ingested an individually calibrated telemetric temperature capsule at least five 
hours (8 a.m.) before the race (start 1 p.m.) to prevent interaction of the T
GI 
measurements 
with fluid ingestion during testing.15 T
GI 
was measured using a portable telemetry system 
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(CorTemp™ system, HQ Inc., Palmetto, USA), which has been demonstrated to safely and 
reliably measure T
GI
 as indicator of the subject’s CBT.16 17 The average of three consecutive 
measurements for each time point was used for further analyses. The T
GI 
rise between 
baseline and finish was calculated by subtracting the T
GI 
at baseline from the T
GI 
at the 
finish line.
Subjects self-reported the amount of fluid intake from the time of getting out of bed 
until the end of the race. Body weight was measured at baseline and within 10 minutes 
after the race, from which the relative change in body weight was calculated (expressed 
as percentage dehydration). Correction for fluid intake during the race was applied by 
adding the amount of fluids consumed to the baseline body weight and recalculating the 
body weight change. Subjects were allowed to drink ad libitum before as well as during 
the race. No restrictions were imposed on the type of fluids consumed, though subjects 
were requested to refrain from drinking between finishing and the second body weight 
measurement to avoid overestimating the post-race body weight.
Individual finish times after 15-km were obtained from the organizational measuring 
system (ChampionChip®, MYLAPS, Nijmegen, the Netherlands), and running speed was 
calculated accordingly.
Wet-bulb Globe Temperature (WBGT) was measured every 30 minutes throughout the 
day using a portable climate-monitoring device (Davis Instruments Inc., Hayward, USA) 
positioned in the start/finish area.
Statistical analyses were performed using the Statistical Package for the Social Sciences 
(IBM SPSS Statistics for Windows, Version 20.0. IBM Corp., Armonk, NY, USA). Data was 
reported as mean ± standard deviation, with the significance level was set at p≤0.05. 
Normality distribution was examined using a Kolmogorov-Smirnov test. In case of non-
Gaussian distribution, log-transformation was performed and the data was re-examined 
for normality distribution. If normal distribution could not be attained, non-parametric 
tests were applied. Differences in subject and exercise characteristics between the race 
editions were analysed using a Student’s t-tests. For study aim 1, a repeated measurements 
ANOVA was used to determine if thermoregulatory responses were comparable between 
race edition 1 and 2. Coefficients of variation expressed as percentage (CoV) were 
determined for each individual subject to gain more insight the individual variation of 
thermoregulatory responses and race speed between both race editions. Subsequently a 
Pearson correlation was used to determine the consistency of finish T
GI 
and the exercise-
induced T
GI 
elevation. For study aim 2 we performed a linear regression analysis with finish 
Chapter 342   |
T
GI 
in race edition 2 as the dependent variable, and age, BMI, fluid intake before the race, 
T
GI 
change during warming-up (original model) and supplemented it with finish T
GI 
in 
race edition 1 as independent parameters.7 To correct for large within-subject differences 
of metabolic heat production (e.g. race speed),6 11 we performed additional analyses in 
which we excluded subjects that showed a >5% difference in race speed between both 
editions. Finally we created 3 dummy parameters (T
GI 
≥39.0°C (yes/no), T
GI 
≥39.5°C (yes/
no), T
GI 
≥40.0°C (yes/no)) for both race editions to explore the risk for exceeding these 
T
GI 
thresholds in the two consecutive road races. A Pearson’s Chi Square test was used to 
calculate Relative Risks (RR) and their 95% confidence intervals (CI).
Results
Subject characteristics (i.e. baseline body weight, BMI and body surface area) did not 
differ between race 1 and 2 (Table 3-1). All subjects successfully completed both races at 
comparable running speeds (11.8±1.9 km/h versus 11.7±1.9 km/h, range 8.1-16.5 km/h; 
p=0.78; CoV 3±3%). Environmental conditions were cool and comparable between race 
edition 1 (WBGT 11°C, T
DRY-BULB
 10.5°C, relative humidity 87%, wind speed 3.4–5.4 m/s) and 
race edition 2 (WBGT 12.5°C, T
DRY-BULB
 11.5°C, relative humidity 88%, wind speed 3.4–7.9 
m/s). Pre-race fluid intake was not different between both race editions (1147±448 mL 
versus 1095±444 mL; p=0.25), whereas fluid intake during the races was higher in race 
edition 2 versus 1 (129±146 mL versus 85±134 mL; p=0.02). Nevertheless, the percentage 
body weight loss was not different between both races (-1.6±0.6% versus -1.5±0.5%; 
p=0.25).
T
GI 
was not different at baseline (37.6±0.4°C versus 37.7±0.4°C; p=0.24; Cov 1±1%, Figure 
3-1), before the start (37.8±0.4°C versus 37.9±0.5°C; p=0.28; CoV 1±1%) and immediately 
after finishing (39.4±0.6°C versus 39.4±0.6°C; p=0.83; CoV 1±1%), and demonstrated 
no difference in exercise-induced T
GI 
increase in both race editions (1.9±0.8°C versus 
1.8±0.8°C; p=0.58). Finish T
GI
 (Pearson’s r=0.50, p<0.001; Figure 3-2A) and the exercise-
induced increase in T
GI
 (Spearman’s r=0.40, p=0.002; Figure 3-2B) correlated significantly 
between both races. Correction for subjects with a >5% (n=14) difference in race speed 
between both race editions improved the correlation of finish T
GI 
between race edition 
1 and 2 (Pearson’s r=0.59, p<0.001). Lastly, a linear regression analysis revealed that the 
higher fluid intake in race 2 did not significantly influence T
GI 
at the finish line in race 2 
(R2 = 0.00; p=0.87). Excluding subjects that consumed <0.5L of fluids 4 hours prior to the 
exercise bout (n=6) and re-analysing the data did not affect the correlation of finish T
GI
 
(r=0.48, p<0.001).
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By applying our original linear regression model to the present subject population we 
were able to predict 17.1% (F-score 2.58, p<0.05) of the finish T
GI 
of race edition 2 (Table 
3-2). Supplementing the model with finish T
GI 
of race edition 1 as an independent variable 
resulted in a higher predictive capacity of the regression model (R2=0.32, F-score 4.66, 
p=0.001; Table 3-2). Interestingly, correction for subjects with a >5% difference in race 
speed resulted in an even stronger predictive model (R2=0.47, p<0.001). Lastly, re-
analysing our data after exclusion of subjects that consumed <0.5L of fluids 4 hours prior 
to exercise did not affect our predictive model (R2=0.31, p<0.01).
Figure 3-1: Gastrointestinal	temperature	(T
GI
)	at	baseline,	1	minute	before	the	start	and	immediately	after	
fi	nishing	in	race	edition	1	(solid	line,	circles)	and	race	edition	2	(dotted	line,	triangles).	T
GI	
was	not	diff	erent	at	all	
time	points	(p=0.30)	and	increased	signifi	cantly	over	time	(p<0.001).
Lastly, runners that demonstrated a finish T
GI 
≥39.0°C in race 1, had a 3.7 times larger 
chance (CI: 1.0 – 14.0) to exceed this T
GI 
threshold again in race edition 2 compared to 
athletes who had a finish T
GI 
lower than 39.0°C in race 1. Likewise, runners with a finish 
T
GI
≥39.5°C and ≥40.0°C in race edition 1 had elevated risks to exceed these T
GI 
levels again 
in race edition 2 (RR: 6.5, CI: 2.0 – 21.0 and RR: 6.0, CI: 1.5 – 24.5 respectively).
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Figure 3-2: Correlation	between	finish	gastrointestinal	temperature	in	race	edition	1	(x-axis)	and	race	edition	
2	(y-axis;	Figure	3-2A)	and	correlation	between	the	gastrointestinal	temperature	increase	(baseline	to	finish)	
between	race	edition	1	(x-axis)	and	race	edition	2	(y-axis;	Figure	3-2B).	The	regression	analysis	revealed	that	
gastrointestinal	temperature	in	race	edition	1	accounted	for	25%	of	the	finish	gastrointestinal	temperature	in	
race	edition	2.	The	dotted	lines	refer	to	the	correlation	coefficients	and	the	solid	lines	refer	to	the	line	of	identity	
(x	=	y).
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Table 3-2: Predictor	characteristics	for	fi	nish	TGI	of	race	e	dition	2	using	our	previously	established	predictive	
model	 (upper	 section)	 and	 our	 new	 model,	 which	 was	 supplemented	 with	 fi	nish	 TGI	 in	 race	 edition	 1	 as	
potential	predictive	factor.
Variable Linear Regression Analysis
Original Model* B 95% CI β
Constant 39.5 38.2 – 40.8
Age -0.02 -0.03 – 0.00 -0.29 NS
BMI 0.04 -0.02 – 0.10 0.18 NS
T
GI
 Rise After Warming-Up 0.30 0.05 – 0.54 0.31 B
Fluid Intake Before Race 0.00 -0.00 – 0.00 -0.18 NS
New Model**
Constant 25.0 16.1 – 33.9
Age -0.01 -0.03 – 0.00 -0.21 NS
BMI 0.03 -0.03 – 0.08 0.14 NS
T
GI
 Rise After Warming-Up 0.19 -0.05 – 0.42 0.20 NS
Fluid Intake Before Race 0.00 -0.00 - 0.00 -0.17 NS
Finish T
GI
 Race 1 0.37 0.15 – 0.59 0.41 A
* R for original model = 0.41; R2 = 0.17; F-score of change: 2.58, p<0.05 / ** R for new model = 0.57; R2 = 0.32; F-score 
of change: 4.66, p=0.001
Ap <0.005; B p <0.05; NS not significant
CI = confidence interval; β = standardized B
Discussion
This study assessed the within-subject variation of thermoregulatory responses in 
athletes participating in two consecutive editions of a 15-km road race in comparable 
environmental conditions. Our results demonstrate that T
GI 
was not different across both 
exercise bouts at baseline, start and finish, and show that both finish T
GI
 (r=0.50) as well 
as the exercise-induced T
GI 
increase (r=0.40) correlated significantly between the two race 
editions. Moreover, by supplementing our predictive model with the finish T
GI 
from the 
first race edition, we improved the predictive capacity of finish T
GI 
from 17.1% to 32.2%. 
Lastly, our results demonstrate that the chance of attaining a high T
GI 
was significantly 
larger if that subject demonstrated previous high exercise-induced thermoregulatory 
responses (relative risk varying from 3.7 – 6.5). These results suggest that CBT responses 
are not different within subjects over consecutive exercise bouts. Therefore, individual 
CBT data are valuable to improve the predictability of exercise-induced thermoregulatory 
responses and to identify which athletes are most likely to benefit from cooling strategies.
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To our knowledge, this is the first study to directly compare and correlate T
GI 
in the same 
subjects performing two similar exercise bouts without applying any intervention. 
Previous studies that measured T
GI 
during repeated exercise bouts reported variable 
results, but are difficult to compare to the present study as they all imposed different 
kinds of potentially confounding interventions, including diurnal variation,18 variable 
environmental conditions,19 variable heat load20 or variable exercise protocols.21 By 
performing measurements in the same subjects who twice completed the same 15-
km run under similar conditions, we were able to directly compare thermoregulatory 
responses whilst limiting the chance of confounders. Indeed, our results showed that 
BMI,22 running speed23 and hydration status,24 which are known to influence CBT during 
exercise, were all similar across both exercise bouts and will therefore unlikely have 
influenced our results. Although fluid intake during the race was significantly higher in the 
second exercise bout (129 ± 146 mL versus 85 ± 134 mL), absolute differences between 
race editions were small (44 ± 150 mL), body weight changes were comparable (-1.6±0.6 
versus -1.5±0.5% of total body weight), and regression analysis showed no impact of fluid 
intake on finish T
GI
. To summarize, the significant correlations of finish T
GI
 (r=0.50) and T
GI 
increase (r=0.40) between both race editions suggest that the correlation of CBT at the 
finish line between two 15-km road races is moderate, whilst the coefficients of variation 
are low within subjects.
Our model that demonstrated a 17.1% predictive capacity for finish T
GI 
confirms previous 
findings (16.7% predictive capacity in a different study cohort).7 By adding the finish T
GI 
from 
race 1 to this model to predict finish T
GI 
in race 2, we were able to improve the predictive 
capacity from 17.1% to 32.2%. Interestingly, correcting our model for changes in exercise 
intensity (<5% difference in finish time between race 1 and 2), further improved the 
predictability of finish T
GI
 (R2=0.47). Furthermore, we demonstrated that individuals, who 
developed a finish T
GI 
≥39.0°C during the first edition, were 3.7 times more likely to attain a 
similar or higher T
GI 
during a second exercise bout compared to subjects who finished with 
a T
GI 
≤39.0°C. This chance was even greater if higher cut-off values were chosen; subjects 
finishing with a T
GI 
≥40.0°C had a 6.0 times greater chance for exceeding this threshold 
again during a subsequent race. These findings may help to identify athletes that benefit 
from cooling interventions preceding and during exercise.25
The limited variation of exercise-induced T
GI 
responses within subjects, in combination with 
the large variation in thermoregulatory responses between subjects (T
GI 
increase ranging 
0.4-3.6°C) raises questions regarding the underlying mechanisms that are responsible 
for this observation. In addition to anthropometric factors such as age,10 sex,9 and BMI8 
10, inherited intrinsic factors might play an important role. For example, several genes 
have been linked to the development of heat illness.10 Whether the genetic variation also 
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affects thermoregulatory responses and/or the capacity of heat dissipating mechanisms is 
currently unknown. Likewise, there is evidence that CBT responses are related to exercise-
induced changes of the hypothalamic setpoint.26 27 Potentially, the ‘high-responders’ 
in our study demonstrated a larger increase in the CBT setpoint compared to the ‘low-
responders’. Since our study did not include measurements of these intrinsic factors, 
future studies focussing on the potential underlying mechanisms are warranted.
This study was limited by the fact that we did not measure hydration status prior to the start 
of the exercise, which could mask differences in hydration status between both exercise 
bouts. However, previous literature recommended that the consumption of ~0.5L of fluids 
4 hours prior to exercise should ensure euhydration at the start of the exercise.28  Whilst 
52 subjects met this criterion, 6 subjects did not. Re-analysis of our data without these 
subjects did not affect the correlation of finish T
GI
 or our predictive model. We therefore 
believe that differences in hydration status did not impact on our findings. Furthermore, 
this study was also limited by the fact that both race editions were separated by a ~1 year 
time span. This could have potentially lead to the occurrence of within-subject differences 
that could not have been accounted for (e.g. changes in health status, training status, 
etc.), possibly resulting in a suboptimal comparison between finish T
GI 
in both editions. 
Nevertheless, we still found a significant correlation of 0.50 in finish T
GI 
between both 
races. Therefore, given that a smaller time span between both exercise bouts might have 
resulted in a higher correlation, our results likely only underestimate the actual within-
subject variation of thermoregulatory responses.
Conclusion
Exercise-induced thermoregulatory responses significantly correlated within subjects 
performing two consecutive conditions of a 15-km road race under cool environmental 
conditions, demonstrated a moderate within-subject variability and a low coefficient 
of variation. Athletes that showed a finish T
GI 
≥40.0°C had a 6.0 times greater chance for 
exceeding this threshold again during a subsequent race. More importantly, the use of 
previously obtained thermoregulatory responses improves the predictability of finish 
core body temperatures in future races. Our findings enable identification of athletes that 
are the most likely to benefit from cooling interventions preceding and during exercise.
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Abstrac t
Purpose: Exercise increases core body temperature (T
C
) due to metabolic heat production. 
However, the exercise-induced release of inflammatory cytokines including interleukin-6 
may also contribute to the rise in T
C
 by increasing the hypothalamic temperature setpoint. 
We aimed to investigate whether the exercise-induced increase in T
C
 is partly caused by an 
altered hypothalamic temperature setpoint.
Methods: 15 healthy, active male subjects aged 36±14 years were recruited. Subjects 
performed submaximal treadmill exercise in 3 randomized test conditions: (1) ibuprofen 
400mg and acetaminophen 1000mg (IBU/APAP), (2) acetaminophen 1000mg (APAP) and 
(3) a control condition (CTRL). Acetaminophen and ibuprofen were used to block the 
effect of interleukin-6 at a central and peripheral level, respectively. T
C
, skin temperature 
and heart rate were measured continuously during the submaximal exercise tests.
Results: Baseline values of T
C
, skin temperature and heart rate did not differ across 
conditions. Serum interleukin-6 concentrations increased in all three conditions. A 
significantly lower peak T
C
 was observed in IBU/APAP (38.8±0.4°C) versus CTRL (39.2±0.5°C, 
p=0.02), but not in APAP (38.9±0.4°C) versus CTRL. Similarly, a lower ΔT
C
 was observed in 
IBU/APAP (1.7±0.3°C) versus CTRL (2.0±0.5°C, p<0.02), but not in APAP (1.7±0.5°C) versus 
CTRL. No differences were observed in skin temperature and heart rate responses across 
conditions.
Conclusions: The combined administration of acetaminophen and ibuprofen resulted in 
an attenuated increase in T
C
 during exercise when compared to a control condition. This 
observation suggests that a prostaglandin E
2
 induced elevated hypothalamic temperature 
setpoint may contribute to the exercise-induced rise in T
C
.
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I ntroduc tion 
Human core body temperature (CBT) is strictly regulated by the body’s natural thermostat 
located in the hypothalamus. CBT is measured by preoptic area neurons and values are 
compared with the temperature setpoint, which is typically kept near 36.8±0.4°C.1 2 When 
CBT increases beyond the setpoint temperature, several compensatory mechanisms are 
activated to release excess body heat and maintain a proper CBT.3 4
Exercise almost invariably causes CBT to rise, as a result of increased metabolic heat 
production due to muscle labor.3 5 6 Since the hypothalamic temperature setpoint remains 
unchanged, a rise in CBT will activate heat loss mechanisms including skin vasodilatation 
and sweating.3 These mechanisms are often insufficient and CBT will rise further.7 Another 
cause for CBT to rise is infection- or inflammation-induced fever, which causes the 
hypothalamic temperature setpoint itself to rise. Multiple pro-inflammatory cytokines are 
released during infection, including interleukin-1β (IL-1β) and interleukin-6 (IL-6).8 These 
cytokines stimulate the enzyme cyclooxygenase (COX) to synthesize prostaglandin E
2
 
(PGE
2
), which in turn upregulates the temperature setpoint and via several mechanisms 
(e.g. vasoconstriction and shivering) may cause CBT to rise.8-11 Antipyretic drugs mainly 
act by reducing PGE
2
 synthesis by inhibiting COX enzyme activity.9 10 COX can be 
inhibited either peripherally (non-steroidal anti-inflammatory drugs) or centrally in the 
hypothalamus (acetaminophen).9 12
Whilst current literature states that metabolic heat production is the sole cause for CBT to 
rise during exercise, previous authors have also reported that substantial amounts of pro-
inflammatory cytokines are released during exercise.13 14 It could therefore be hypothesized 
that the release of these cytokines during exercise can increase the hypothalamic setpoint, 
and may thus be partially responsible for the exercise-induced CBT rise. 
Recent human studies suggested that drug-induced inhibition of PGE
2
 synthesis may15-
17 or may not18 attenuate the rise in CBT and skin temperature during exercise. These 
inconsistent findings may be explained by the different modes of exercise protocols 
(incremental vs. fixed intensity), but may also be caused by the fact that these studies 
inhibited COX-enzyme activity either centrally (acetaminophen) or peripherally (non-
steroidal anti-inflammatory drugs). Since none of these studies used COX-inhibition via 
both pathways, to what extent inflammatory cytokines influence the CBT rise during 
exercise still needs to be elucidated.
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The aim of this study was to investigate whether combined inhibition of central 
(acetaminophen) and peripheral (ibuprofen) PGE
2
 synthesis can attenuate the rise in CBT 
during exercise. We hypothesized that the exercise-induced CBT elevations are attenuated 
in the combined COX inhibition conditions versus the control condition.
M ethods
Fifteen healthy male volunteers unacclimatized to heat were included in this study (Table 
4-1). Potential subjects were eligible to participate if they were aged between 18-60 years and 
performed regular running exercise for at least 1.5 hours per week. After providing written 
informed consent, potential subjects were screened for the presence of any exclusion criteria 
for using the COX-inhibitors or for using the temperature pill: I) a known hypersensitivity to 
acetaminophen or non-steroidal anti-inflammatory drugs II) a peptic ulcer in the medical 
history, III) a history of kidney disease, IV) a history of obstructive/inflammatory bowel 
disease or surgery (with exception of appendectomy and cholecystectomy), V) having 
an electrically implanted device, or VI) scheduled a MRI-scan within 5 days after the test-
day. Study procedures were approved by the Radboud university medical center Ethics 
Committee and accorded to the principles of the declaration of Helsinki.
Table 4-1. Subject	characteristics	and	results	of	the	maximal	exercise	test.	
Mean ± SD Range
Age (yrs) 36 ± 14 21 - 59
Body Mass Index (kg/m2) 22.8 ± 1.9 19.2 - 27.4
Height (cm) 181 ± 8 170 - 190
Training time (hours / week) 4.4 ± 2.6 1.5 - 11
Maximal Heart Rate (bpm) 186 ± 11 159 - 197
VO
2
max (mL/min/kg) 61.7 ± 9.9 43.1 - 78.0
Lactate pre-test (mmol/L) 1.5 ± 0.9 0.8 - 4.4
Lactate post-test (mmol/L) 13.9 ± 3.2 7.9 - 18.5
Each subject visited our laboratory four times. During the first visit, subjects performed a 
maximal treadmill exercise test to determine each subject’s maximal heart rate. Visits 2 to 4 
consisted of submaximal exercise tests on a treadmill where running speed was calibrated 
individually for each subject’s maximal heart rate. Each submaximal exercise test comprised 
of 30 minutes continuous running at 85% of the subject’s maximal heart rate, followed 
by 10 intervals with a 1 minute speed increase of 2km/h and 2 minute speed decrease of 
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2km/h compared to the continuous running speed of the first 30 minutes. This exercise 
protocol was selected based on pilot measurements within our own department to select 
the exercise protocol that elicits the strongest T
C  
rise within one hour. Running speeds of 
the second and third exercise test were kept identical to the first exercise test to ensure that 
stimuli for thermogenesis and cytokine release were identical across all exercise tests. Using 
a cross-over design with randomization of sequences, the following test medication was 
administered 45 minutes before the start of each submaximal exercise test.
1. IBU/APAP: Administration of 400mg ibuprofen (IBU) with 100mL of water and 
1000mg acetaminophen (APAP) with 100mL of water.
2. APAP: Administration of 1000mg acetaminophen with 100mL of water. An extra 
100mL of water was administered as a control substance for ibuprofen. This condition 
was added for comparison with previously performed studies using APAP only.15 18 19
3. CTRL: Control condition without inhibition of PGE
2
 synthesis. Instead, 100mL of water 
was administered twice as control substances for acetaminophen and ibuprofen.
The use of the non-steroidal anti-inflammatory drug ibuprofen was chosen because 
of pharmacokinetics similar to acetaminophen. Since ibuprofen reaches its maximal 
plasma concentration 1-2 hours after ingestion, and acetaminophen reaches its maximal 
concentration 30 minutes to 2 hours after ingestion, administration of the test medication 
was timed such that maximal concentrations were attained 30 to 45 minutes into the 
exercise bout. The dosage of both APAP and IBU was based on the Dutch Guidelines for 
antipyretic treatment.20 A minimum of 3 rest days was required between the submaximal 
exercise tests to enable full recovery, and subjects were not allowed to use acetaminophen 
or NSAIDs for at least 3 days preceding each measurement. All experiments were 
performed in the same room at the same temperature (21°C) and humidity (45%) and the 
same time of the day to prevent any interference of environmental conditions or circadian 
rhythm.4 Also, subjects were instructed to consume 500mL of water 2-3 hours before the 
start of the exercise tests to ensure euhydration at the start of the exercise bouts.21
Each subject underwent a maximal exercise test on a treadmill (GTR-3.06, En-Bo Systems, 
Zwolle, Netherlands) using the Bruce protocol. Oxygen consumption was measured using 
a calibrated gas exchange analyser (Quark CPET, Cosmed, Italy) with a breathing mask. 
Heart rate was monitored using a Cosmed HR monitor (Cosmed, Italy). Capillary blood 
lactate levels were measured (Lactate Pro, Arkray, Kyoto, Japan) before and after the 
maximal exercise test as an indicator for achieving maximal exercise (>8 mmol/L). Other 
indicators for maximal exercise were a plateau in the VO
2
-curve, a respiratory exchange 
ratio ≥1.1, and a maximal heart rate ≥95% of the age-predicted maximum. Subjects had 
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to meet 3 out of the 4 aforementioned criteria to achieve maximal exercise.
The subjects were instructed to ingest a telemetric temperature pill (CorTemp, HQ Inc, 
Palmetto Fl, USA) 6 hours prior to each submaximal exercise test to assure stomach passage 
and exclude interference from fluid or food ingestion.22 Using an external recorder CBT 
was recorded every 20 seconds and averaged per minute. This method is known to be 
valid and safe, and was described in detail previously.23
The skin temperature (T
SK
) was measured during each test using individual skin 
temperature sensors (iButtons, Maxim Integrated, San Jose, CA, USA). T
SK
 was measured 
every 30 seconds with a resolution of 0.0625°C. Using the ISO 9886 norm, 8 different 
iButtons were attached to the skin: on the forehead, right scapula, left thorax, right upper 
arm, left lower arm, left hand, right upper leg and left calf. Mean T
SK
 was calculated from a 
standard area weighing factors,24 and averaged per minute.
To compare the exercise intensity during the submaximal exercise tests the heart rate 
was measured in beats per minute using a chest band system (Polar RS800, Oy, Kempele, 
Finland). The heart rate was measured every 15 seconds and averaged per minute.
To assess sweat losses, body weight was measured immediately before and after each 
exercise bout, after subjects towelled off sweat and with subjects wearing shorts and 
underwear only (Seca 888 scale, Hamburg, Germany). Relative body weight changes were 
calculated to assess the hydration status of subjects.
To compare the stimulus for PGE
2
 synthesis in every test condition a venous blood sample 
was taken to measure the concentration of IL-6 at baseline (before taking the medication) 
and directly after completing the exercise test. A 10mL K3EDTA vacutainer tube was 
used to collect the blood sample and was immediately after collection centrifuged at 
4°C and 3600 rpm for 12 minutes. All samples were subsequently stored at -80°C until 
further analysis. All blood samples were analysed on the same day after completing all 
experimental tests. A commercial IL-6 ELISA kit (Pelipair human IL-6 ELISA kit, Sanquin, 
Amsterdam, the Netherlands) was used for determining IL-6 concentrations. The detection 
limit of the IL-6 ELISA kits was 3 pg/ml.
Rate of perceived exertion (RPE) was measured every 6 minutes using the BORG-scale.25 
This scale ranges from 6-20 with 6 being very mild and 20 the most strenuous exercise. 
Furthermore we asked subjects to rate Thermal Sensation and Thermal Comfort every 6 
minutes. Thermal Sensation measures the temperature perception of the subject with 
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a scale ranging from -3 being really cold to +3 being really hot. Thermal Comfort is a 
measure of how comfortable the temperature feels to the subject ranging from -4 being 
very comfortable to +4 being very uncomfortable.26
All data are presented as mean ± standard deviation unless indicated otherwise. Statistical 
analyses were conducted using SPSS version 20 (IBM SPSS version 20.0, Armonk, NY, 
USA). Changes over time (baseline vs. peak) and between conditions (IBU/APAP/CTRL) 
were analysed using a within-subject repeated-measures ANOVA. Delta (Δ) CBT and T
SK
 
were determined as the difference between maximal value and baseline value. Group 
differences at the same time point (e.g. ambient temperature, baseline or peak CBT) were 
analysed using a within-subject one-way ANOVA.  Due to the fact that some baseline 
values of the IL-6 concentrations were below the detection limit, a logistic regression 
analysis was performed to test whether more values were above the detection limit post-
exercise compared to baseline. In case of a significant outcome a post-hoc Bonferroni test 
was applied. The level of significance was set at p≤0.05.
Results 
All subjects successfully completed the maximal and submaximal exercise tests (Table 
4-1). All subjects completed the entire study protocol within 4 weeks. Room temperature 
(IBU/APAP 21.1±0.9°C, APAP 21.3±0.6°C, CTRL 21.1±1.0°C, p=0.80) and humidity (IBU/APAP 
42.3±9.1%, APAP 45.0±11.0%, CTRL 43.5±7.5%, p=0.60) were similar across the three test 
conditions. VO
2 MAX
 was 61.7 ± 9.9 mL/min/kg. Maximal heart rate was 186 ± 11 bpm. No 
adverse events occurred and all subjects met the criteria for achieving maximal exercise.
CBT was similar at baseline across the three conditions (IBU/APAP 37.1±0.2°C, APAP 
37.3±0.2°C, CTRL 37.1±0.2°C; p=0.16). CBT increased significantly over time (p<0.001), 
and a significant time*condition interaction was found (p=0.048). Maximum CBT was 
significantly lower in the IBU/APAP condition compared to the CTRL condition (IBU/
APAP 38.8±0.4°C versus CTRL 39.2±0.5°C; p=0.02) but not between APAP and CTRL (APAP 
38.9±0.4°C). A lower ΔCBT was observed in the IBU/APAP condition versus the CTRL 
condition (IBU/APAP 1.7±0.3°C versus CTRL 2.0±0.5°C; p=0.042; Figure 4-1A). ΔCBT did not 
differ between APAP and CTRL (APAP 1.7±0.5°C).
T
SK
 was similar at baseline in all three conditions (IBU/APAP 31.8±0.4°C, APAP 32.0±0.4°C, 
CTRL 31.8±0.5°C; p=0.23). T
SK
 increased significantly over time in all conditions (p<0.001), 
though no differences across conditions (p=0.42) or time*condition (p=0.52) were found. 
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Figure 4-1A:  Core	Body	Temperature	(CBT)	during	exercise	during	the	exercise	bouts.	B:	Skin	Temperature	
(TSK)	during	the	exercise	bouts.	C:	Heart	Rate	(HR)	during	the	exercise	bouts.	For	readability	purposes,	the	error	
bars	are	not	visualized	on	the	same	time	points.
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Also, there were no differences in maximum T
SK
 (IBU/APAP 34.2±0.6°C, APAP 34.3±0.6°C, 
CTRL 34.2±0.6°C; p=0.95) or ΔTsk (IBU/APAP 2.3±0.6°C, APAP 2.3±0.7°C, CTRL 2.4±0.6°C; 
p=0.53) across conditions (Figure 4-1B).
Before the start of the sub-maximal exercise tests, heart rate was similar across conditions 
(IBU/APAP 106±15 bpm, APAP 107±12 bpm, CTRL 102±15 bpm; p=0.51). Heart rate increased 
significantly over time in all conditions (p<0.001), though no significant condition*time 
interaction occurred (p=0.28). No differences in maximal heart rate (IBU/APAP 168±10 bpm, 
APAP 170±10 bpm, CTRL 172±6 bpm; p=0.35) or delta heart rate (IBU/APAP 64±16 bpm, 
APAP 64±19 bpm, CTRL 69±14 bpm; p=0.28) were observed across conditions (Figure 4-1C).
The prevalence of IL-6 concentration in serum exceeding the level of detection (>3mmol/L) 
was low across all conditions at baseline (IBU/APAP n=1 (7%; range 7), APAP n=3 (20%; 
range 3-24), CTRL n=1 (7%; range 4), whilst a substantially higher amount of samples post-
exercise showed levels exceeding the level of detection (IBU/APAP n=10 (67%; range 3-8), 
APAP n=7 (47%; range 4-11), CTRL n=12 (80%; range 3-10)). No significance levels could 
be determined to compare pre- versus post-exercise values due to the low number of 
samples being below the level of detection pre-exercise.
Maximal RPE and average RPE were not different among conditions (Table 4-2). No 
significant differences were observed among conditions in maximal and average thermal 
comfort. There were no differences among conditions in maximal and average thermal 
sensation. Body weight change was similar across all conditions (Table 4-2).
Table 4-2:	Rate	of	perceived	exertion,	thermal	comfort,	thermal	sensation	scores	and	body	weight	change	
during	the	submaximal	exercise	tests.	
IBU/APAP APAP CTRL P-Value
RPE max (au) 13.9 ± 1.8 13.2 ± 2.2 13.2 ± 1.6 0.36
RPE average (au) 11.9 ± 1.0 11.6 ± 1.6 11.8 ± 1.2 0.57
Thermal Comfort max (au) 1.7 ± 1.2 1.7 ± 1.1 1.7 ± 1.1 0.97
Thermal Comfort average (au) 0.8 ± 1.1 0.7 ± 1.0 0.5 ± 0.9 0.16
Thermal Sensation max (au) 1.9 ± 0.8 1.9 ± 0.8 2.0 ± 0.6 0.86
Thermal Sensation average (au) 1.3 ± 0.5 1.3 ± 0.6 1.4 ± 0.6 0.88
Body weight change (%) -1.6 ± 0.3 -1.5 ± 0.2 -1.5 ± 0.3 0.66
RPE: Rate of Perceived Exertion. IBU/APAP: peripheral and central COX inhibition by ibuprofen and acetaminophen. 
APAP: central COX inhibition by acetaminophen. CTRL: control condition. AU: arbitrary units
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Discussion
The aim of this study was to investigate the effect of combined inhibition of central 
and peripheral PGE
2
 synthesis on the rise in T
C
 during exercise. We found a significantly 
lower maximal T
C 
with combined inhibition (IBU/APAP) compared to CTRL, whilst central 
inhibition only (APAP) was not different from CTRL. No significant differences in maximal 
T
SK
, heart rate, body weight change and RPE were observed across conditions. These 
results suggest that exercise-induced PGE
2
 synthesis may impact on the thermoregulatory 
setpoint and may therefore contribute to the increase in T
C
 during exercise in humans.
The present study was performed under similar environmental circumstances in all three 
test conditions. Furthermore the intensity of exercise was identical across conditions, 
ensuring equal thermogenesis and release of pro-inflammatory cytokines was identical 
during each test. The measurements were performed in moderate temperatures since 
we wanted to replicate conditions similar to those typically encountered in recreational 
running. The randomization of all three conditions rules out a potential training effect. 
Although significance levels could not be determined, IL-6 levels showed a similarly low 
prevalence of values exceeding the level of detection pre-exercise, as well as a substantially 
higher prevalence exceeding the level of detection post-exercise. Whilst no significance 
levels could be determined for this difference, it does suggest that elevated IL-6 levels 
during exercise posed as stimulus for PGE
2
 production across all conditions in line with 
previous literature13 14. Also, the lack of differences in body weight loss across conditions 
out rules any influence by differences sweat losses. Lastly, the study protocol was not 
blinded since humans are unable to (sub)consciously alter their body temperature and 
since the exercise protocols were kept identical (i.e. identical metabolic heat production 
during each exercise test). Blinding was therefore not expected to alter our results.
A significantly lower maximum T
C
 and ΔT
C
 were found in the IBU/APAP compared to the 
CTRL condition, but not between the APAP and CTRL condition. These observations 
support our hypothesis and suggest a superior effect of simultaneous central and 
peripheral COX inhibition, although a similar effect of central inhibition and combined 
inhibition cannot be completely ruled out given the similar delta T
C
 between IBU/APAP 
and APAP. Whilst we did not identify a significant effect of APAP alone, previous authors 
did15 16. Possible explanations for this may be differences in the exercise protocol15 16, 
ambient conditions15 16 or training status16. The primary site of action for acetaminophen 
is the inhibition of PGE
2
 synthesis in the brain through the inhibition of the COX-1 and 
COX-2 enzyme9 27. Ibuprofen is a non-selective cyclooxygenase inhibitor in the NSAID 
group and the mechanism of action is lowering PGE
2
 by directly inhibiting COX-1 and 
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COX-2 enzyme activity peripherally9. Because acetaminophen and ibuprofen act as COX-
enzyme inhibitors on a central respectively a peripheral level they maximally inhibit 
PGE
2
 synthesis produced by exercise-induced IL-6 release. Whilst COX has been shown to 
not affect forearm sweating28,  a clinical study suggested that the combined therapy of 
acetaminophen and ibuprofen is more effective in lowering T
C
 during fever29. The present 
study expands this observation to an exercise setting. Especially since previous human 
studies that used drug-induced inhibition of PGE
2
 synthesis during exercise15-18 used either 
central or peripheral COX inhibitors and reported conflicting results. Our study adds to 
this that the combination of central and peripheral COX inhibition is more effective than 
central COX inhibition only. This may also suggest that circulating prostaglandins from 
the periphery may also influence T
C
, in addition to centrally synthesized prostaglandins. 
Moreover, exercise-induced PGE
2
 synthesis impacts on the thermoregulatory setpoint and 
thus contributes to the increase in T
C
. Whilst the difference of maximum T
C
 between all 
three conditions is small, we believe the difference is still relevant given the competitive 
nature of exercise in which even the smallest difference is important.
When T
C
 rises, mechanisms are activated to dissipate heat to the surroundings. One of 
these mechanisms is an elevated skin blood flow. Vasodilatation causes skin blood flow to 
increase so that warmer blood from the core is transported to the periphery and T
SK
 will 
rise3. One previous study showed a lower T
SK
 when acetaminophen was administered in 
comparison to a placebo16. Simultaneously they found a lower T
C
 in the acetaminophen 
group. Three other studies that investigated acetaminophen or a non-steroidal anti-
inflammatory drug did not find a difference in T
SK
15 17 18. We did not find any differences 
in T
SK
 across conditions either. Ambient temperatures were similar across conditions and 
have thus affected T
SK
 in a similar way. Whilst changes in T
C
 do affect T
SK
, it has also been 
suggested that when T
C
 exceeds the value of 38°C the increase in skin blood flow during 
exercise is attenuated30. As all study participants demonstrated a maximum T
C
 >38°C, this 
might explain the observation that T
SK
 did not differ across conditions in the present study.
Our main goal was to investigate whether an altered setpoint plays a role in the rise in T
C
 
during exercise for a better understanding of thermoregulation during exercise in humans. 
The combined central and peripheral COX blockade using acetaminophen and ibuprofen 
resulted in a slightly but significantly lower maximal T 
C
 (0.3°C) compared to no COX 
blockade at all. This suggests that the exercise-induced rise in T 
C
 may be partially explained 
by an elevated temperature setpoint. The limited T
C 
difference makes it uncertain whether 
the elevated setpoint impacts athletic performance, though further research into this is 
needed. Whilst we would not recommend chronic use of acetaminophen and ibuprofen 
during exercise to lower T
C
 given the potential adverse effects such as kidney damage 
Chapter 464   |
and gastro-intestinal problems, occasional use might be beneficial for athletes to slightly 
reduce their T
C
 at times of high thermal stress and improve exercise performance16 31.
Conclusion
In conclusion, combined administration of acetaminophen and ibuprofen results in an 
attenuated maximal T
C
 during exercise compared to a control condition. This suggests 
that besides the production of metabolic heat, the release of pro-inflammatory cytokines 
contributes to an elevated hypothalamic thermoregulatory setpoint via increased levels 
of PGE
2
. Our results suggest that an upregulated hypothalamic temperature setpoint 
might partially be responsible for the exercise-induced T
C
 rise.
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Abstrac t
Study Design: Observational study.
Objectives: Spinal cord injured (SCI) individuals are thermoregulatory compromised due 
to an inability to vasodilate and sweat below the injury, increasing the risk, proportional 
to the injury level, for marked core body temperature (CBT) rises. We compared 
thermoregulatory responses between wheelchair tennis players with and without a SCI.
Setting: British Open 2013, Nottingham, UK.
Methods: Eight (3 SCI; 5 non-SCI) wheelchair tennis players played a 45-minute match 
whilst we continuously measured CBT, 8-point skin temperature (Mean-Tsk) and exercise 
intensity (METs). Thermal sensation and perceived exertion were measured before and 
after each set. Video-assisted logging of each serve, stroke and point duration was used 
to determine match intensity. No statistics were performed for CBT due to small sample-
sizes.
Results: Wet-bulb Globe Temperature varied between 18-20°C. CBT increased stronger in 
the SCI players (+0.6±0.1°C; n=2) compared to the non-SCI players (+0.3±0.1°C; n=4), whilst 
Mean-Tsk was similar between groups (p=0.29). No Tsk differences were observed above 
(>T6) or below (≤T6) the lesion level. Thermal sensation, perceived exertion, exercise and 
match intensity were similar between groups (all p>0.05).
Conclusions: In this small, descriptive study, CBT increased slightly more in the SCI 
wheelchair tennis players compared to non-SCI players during a 45-minute match in 
moderate environmental conditions. Further research to investigate whether SCI players 
are more prone to heat illness is warranted.
Sponsorship: Funding by the Royal Netherlands Lawn Tennis Association, Amersfoort, 
the Netherlands; NOC*NSF, Arnhem, the Netherlands; International Tennis Federation, 
London, UK; and Radboud University Medical Centre, Nijmegen, the Netherlands.
Thermoregulatory Responses in Wheelchair Tennis Players: A Pilot Study |   71
5
I ntroduc tion
The major tournaments in tennis, such as the Australian and US Open, are often played 
under highly demanding conditions, where ambient temperatures of >35°C have 
been reported. An elevated core body temperature (CBT) is known to reduce exercise 
performance or may even pose a threat to any athlete’s wellbeing by progressing to 
heat illness, and in extreme cases multi-organ failure or even death.1-3 Mediated by local 
and systemic (i.e. neural) pathways, the body’s principal thermoregulatory mechanisms 
in response to an elevated CBT during exercise are cutaneous vasodilatation and active 
sweat secretion.4 5
In spinal cord injured (SCI) individuals the neural transmission of thermoregulatory 
signals is interrupted, leading to an inability to vasodilate and sweat below the level of 
the lesion.6 Higher lesion levels therefore produce a larger body surface area that cannot 
actively regulate body temperature, resulting in a greater risk for heat-related problems. 
In laboratory settings, upper body exercise of similar intensity in SCI individuals and 
able-bodied controls was shown to result in a substantially higher increase in CBT in SCI 
subjects.7-9 However, no previous study has assessed the thermal strain in wheelchair 
tennis players with and without a SCI during a match. This is of special importance since 
the major tournaments for elite wheelchair tennis players are frequently played under 
hot and humid ambient conditions, for instance in view of the 2016 Paralympics in Rio de 
Janeiro.
The aim of this pilot study was to compare the thermoregulatory responses in wheelchair 
tennis players with and without a SCI during an outdoor tennis match. We hypothesized 
that SCI players would exhibit a larger CBT rise during the match compared to the non-SCI 
players.
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M aterials  and methods
Subjects
Eight elite, international-level wheelchair tennis players (3 SCI; 5 non-SCI) were included 
in the study (Table 1). All measurements were performed on-site during a single day at 
the British Open 2013 in Nottingham, United Kingdom. Due to the use of the telemetry 
system for measuring CBT, subjects with a history of (inflammatory) bowel disease or 
any abdominal surgery were excluded from this specific measurement. This study was 
approved by the ethics committee of the Radboud University Medical Centre, and all 
subjects provided a written informed consent before participation. We certify that all 
applicable institutional and governmental regulations concerning the ethical use of 
human volunteers were followed during the course of this research.
Table 5-1: Individual	subjects	characteristics.	SCI:	Spinal	cord	injured;	Non-SCI:	Non-spinal	cord	injured
Subject Group Sex Age 
(yrs)
Height 
(m)
Weight 
(kg)
Nature of Disability
1 SCI M 19 1.65 53.1 Brain stem infarction (ASIA B/C)
2 SCI F 35 1.67 61.0 Traumatic SCI at T6 and L2 (ASIA C/D)
3 SCI M 35 1.79 91.1 Traumatic SCI at T6 (ASIA A)
4 Non-SCI M 34 1.23* 45.5* Amputation of left leg just distal to hip joint 
and right leg just proximal to knee joint
5 Non-SCI M 27 1.57 42.9 Diastrophic dysplasia
6 Non-SCI M 20 1.50 47.5 Cerebral palsy
7 Non-SCI F 18 1.60 41.8 Complete amputation of right leg
8 Non-SCI F 32 1.60 53.1 Cerebral palsy; right-sided hemiplegia
* Measured without prosthesis
Experimental Procedures and Materials
All measurements were performed at outside courts. Subjects were instructed to warm-up 
for a fixed 5-minute period and subsequently play a simulated 45-minutes singles match 
against a similarly ranked opponent that also participated in the study. Measurements 
were started before the warming-up and continued throughout the match.
Core Body Temperature
Participants ingested an individually calibrated telemetric temperature pill, which 
measured (intestinal) CBT and transmitted the temperature via radio waves to an external 
recorder (CorTemp; HQ, Palmetto, FL, USA) that was attached underneath each participant’s 
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wheelchair. This measuring system has been demonstrated to safely and reliably measure 
CBT during exercise and rest.10 11 The wireless signal was recorded every 20 seconds and 
was post-hoc averaged for each minute.
Skin Temperature
We measured Skin Temperature (Tsk) every 30 seconds throughout the match by 
attaching wireless data loggers directly onto the skin (iButton; Maxim Integrated, San 
Jose, CA, USA) using Tegaderm transparent film dressing (Tegaderm™ Film 1624, Neuss, 
Germany). Use of these data loggers to measure Tsk has been validated and described 
in previous studies.12 Tsk was measured at a resolution of 0.0625°C by attaching the data 
loggers on the forehead, right scapula, upper left thorax, right upper arm, left forearm, 
left hand, ventral side right upper leg and left calf. Mean-skin temperature (Mean-Tsk) was 
calculated according to ISO 9886 and averaged for each minute.13 Tsk was further divided 
into an upper region above the lesion level (>T6) and a lower region below the lesion level 
(≤T6; i.e. right upper leg and left calf ) to identify any differences in Tsk relating to the SCI. 
The level of T6 was chosen since all our subjects had their SCI distal to this level.
Thermal Sensation, Perceived Exertion and Exercise Intensity
Thermal sensation (7-point scale: -3 cold; +3 hot) and rating of perceived exertion 
(15-grade BORG scale) were assessed after each completed set.14 15 Exercise intensity was 
determined using an accelerometer (SenseWear Pro3; Bodymedia, Pittsburg, PA, USA), 
which expressed exercise intensity in metabolic equivalent units (METs) for every minute 
played. The accelerometer was worn on the right upper arm throughout the match. 
Previous studies have demonstrated this method to validly and accurately measure 
energy expenditure including in wheelchair users.16
Video-assisted Logging of Match Intensity
In addition to the accelerometry data, alternative descriptive parameters concerning the 
intensity of the matches were obtained by video-recording all matches. A specifically 
developed tablet-app was used to manually tag the time point on which a point started 
(serve) and on which a point ended (ball was out, hit the net, hit the ground ≥3 times or 
hit the ground behind the player). This data was used to extract the average rally and rest 
duration. Stroke frequency was determined by manually counting the number of times 
that a ball was hit during each rally divided by the rally duration. These parameters were 
defined and determined in accordance with previous literature.17
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Environmental Conditions
Wet-bulb Globe Temperature (WBGT) was measured using a portable weather station 
(Davis Instruments, Hayward, CA, USA) every 60 minutes throughout the day. This 
measurement allows for standardization of environmental conditions by accounting 
for outside temperature (T
DRY-BULB
), outside temperature with correction for humidity 
(T
WET-BULB
) and (solar) radiation (T
GLOBE
). WBGT was calculated using the following formula:
WBGT = 0.1 · (T
DRY-BULB
)
 
+ 0.7 · (T
WET-BULB
) + 0.2 · (T
GLOBE
).3
Statistics
Statistical analyses were performed using IBM SPSS version 20.0 (IBM Corp., Armonk, 
NY, USA). Data was reported as mean ± standard deviation unless otherwise indicated. 
Due to the small sample-size no statistical analyses could be performed for the CBT data. 
Normality distribution was tested using a Shapiro-Wilk test. All normally distributed 
data was analysed using parametric tests (t-test and two-way repeated measurements 
ANOVA), and in case of non-Gaussian distribution non-parametric tests were applied 
(Mann-Whitney U test). The level of significance was set at p≤0.05.
Results
Two subjects (1 SCI, 1 non-SCI) were excluded from CBT measurements due to prior 
abdominal surgery. All measurements were performed in moderate environmental 
conditions (WBGT 17.9–20.0°C, T
DRY-BULB
 21.2-24.8°C, T 
GLOBE
 21.7-26.3°C, relative humidity 
51.8-61.4%) with a complete cloud overcast. 
The individual CBT for the SCI subjects and mean CBT for the non-SCI subjects are reported 
in Figure 1, and showed a slightly larger CBT increase in the SCI subjects (+0.6±0.1°C; n=2) 
compared to the non-SCI subjects (+0.3±0.1°C; n=4).
Before the match, we found no significant differences between groups in mean-Tsk 
(p=0.58). A significant change in mean-Tsk was reported over time (p<0.001; Figure 2A), 
whilst no differences were observed between SCI and non-SCI players (p=0.29). Tsk in the 
upper region changed significantly over time (p<0.001; Figure 2B), whilst no differences 
between both groups were reported (p=0.66). No differences were reported in the lower 
region Tsk over time (p=0.42) or between groups over time (p=0.99).
Thermal sensation increased similarly from ‘cold’ to ‘warm’ in both groups (Table 2). Rating 
of perceived exertion was similar at baseline (SCI 9.3±2.9, non-SCI 8.6±1.8; p=0.54) and 
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increased to similar levels at the end of the second set (SCI 13.7±1.2, non-SCI 13.2±2.5; 
p=0.61). Average exercise intensity levels (in METs) were similar throughout the match in 
both groups (4.9±0.7 versus 4.9±0.7; p=1.00). Match intensity parameters are reported in 
Table 2, and showed no differences between both groups.
Figure 5-1:	 Core	 body	 temperature	 throughout	 the	 match	 in	 the	 two	 individual	 SCI	 subjects	 (solid	 lines)	
and	the	non-SCI	group	(open	circles).	The	grey	area	represents	the	warming-up	period.	Data	are	presented	as	
individual	values	(SCI	subjects)	and	mean	±	SEM	(non-SCI	subjects).
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Figure 5-2: Mean	skin	temperature	(A)	throughout	the	match	in	the	SCI	group	(open	squares)	and	the	Non-
SCI	 group	 (open	 circles).	 The	 grey	 area	 represents	 the	 warming-up	 period.	 Mean-Tsk	 changed	 signifi	cantly	
throughout	the	match	in	both	groups	over	time	(2W	RM	ANOVA:	p<0.001),	whilst	no	diff	erences	were	reported	
observed	between	SCI	and	Non-SCI	players	(time	x	group:	p=0.29).	Skin	temperatures	in	the	upper	skin	region	
above	(>T6)	and	in	the	lower	skin	region	below	(≤T6)	the	level	of	the	spinal	cord	injury	are	shown	(B)	for	the	
SCI	group	(upper	region	open	squares;	lower	region	closed	squares)	and	the	non-SCI	group	(upper	region	open	
circles;	 lower	 region	 closed	 circles).	 A	 signifi	cant	 change	 was	 observed	 in	 both	 groups	 in	 the	 upper	 region,	
however	no	diff	erences	were	observed	between	the	SCI	and	Non-SCI	players.	In	the	lower	region,	no	diff	erences	
were	observed	throughout	the	match	(p=0.42)	or	between	both	groups	of	players	(p=0.99).	Data	are	presented	
as	mean	±	SEM.
A
B
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Table 5-2:	Match	and	exercise	intensity	parameters	throughout	the	match,	thermal	sensation	and	rating	of	
perceived	exertion	at	baseline,	after	the	fi	rst	set	and	immediately	after	the	match.	P-values	refer	to	a	Mann-
Whitney	U	test.	SCI:	Spinal	cord	injured;	Non-SCI:	Non-spinal	cord	injured.
SCI
(n=3)
Non-SCI
(n=5)
P-value
Match Intensity
Duration of Rallies (sec) 8.4 ± 1.1 9.8 ± 2.1 0.36
Rest Time Between Points (sec) 21.7 ± 2.8 20.1 ± 3.0 0.36
Work : Rest Ratio 1 : 4.0 ± 1.5 1 : 3.3 ± 1.4 0.36
Effective Playing Time (% of total time) 21.3 ± 7.6 25.2 ± 7.5 0.36
Strokes per Rally (n) 3.7 ± 0.8 4.0 ± 0.7 0.76
Stroke Frequency (str/min) 26.1 ± 2.2 24.6 ± 2.6 0.36
Exercise Intensity (METs) 4.9 ± 0.7 4.9 ± 0.7 1.00
Thermal Sensation
Baseline -1.0 ± 0.0 -0.8 ± 1.3 0.33
After 1st Set 1.7 ± 1.2 1.2 ± 0.4 0.56
After 2nd Set 1.0 ± 1.7 1.6 ± 0.5 0.86
Rating of Perceived Exertion (BORG)
Baseline 9.3 ± 2.9 8.6 ± 1.8 0.54
After 1st Set 12.3 ± 2.3 12.8 ± 1.8 0.76
After 2nd Set 13.7 ± 1.2 13.2 ± 2.5 0.61
Data are presented as mean ± SD
Discussion
The present study was the first to describe changes in CBT during exercise in wheelchair 
tennis players with and without a SCI. Our results are indicative that wheelchair tennis 
causes a rise in CBT under moderate environmental conditions, and that this rise may 
be stronger in SCI players compared to non-SCI players in spite of similar Tsk responses. 
These findings may have clinical and practical importance for SCI players, particularly 
whilst playing tennis matches that are organized in hot and humid conditions as can be 
expected during most Grand Slam tournaments or the 2016 Paralympics in Rio de Janeiro.
CBT showed a larger rise in the SCI subjects compared to the non-SCI subjects. Whilst it 
is difficult to draw any firm conclusions based on these descriptive data, these results are 
in support of our hypothesis and are in agreement with findings in previous laboratory-
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based studies.7-9 18 In able-bodied subjects, exercise intensity is strongly correlated to CBT 
increases.3 The similar exercise intensity, match intensity and RPE between both groups 
suggest that these factors cannot explain the larger CBT rise in the SCI players.
Furthermore, is has been previously described that whilst paraplegic athletes show CBT 
responses similar to able-bodied athletes during exercise in moderate to hot conditions, 
the SCI athletes have a greater heat-storage in the lower body which results in a reduced 
ability to lower their CBT during recovery periods.9 This observation is of particular 
importance in wheelchair tennis, since tennis is typically characterized by bouts of 
exercise (rallies) alternated by periods of relative rest (e.g. ball retrieval and preparation 
phase for next serve). This means that whilst the non-SCI players may be able to cool 
down during the rest periods in between rallies, the SCI players will not be able to do so 
as effectively. Therefore, an attenuated heat loss capacity in the SCI players, resulting from 
a severely reduced body surface area for active thermoregulation and increased lower-
body heat storage, may be responsible for the observed CBT rise in our SCI subjects. As 
our measurements were performed under moderate conditions, differences between 
SCI and non-SCI wheelchair players may be exaggerated under hot conditions, placing 
SCI wheelchair players at potential risk for an impaired performance or developing heat 
illness during tournaments in the heat. Lastly, since the test matches in the present study 
were relatively short in duration compared to a typical wheelchair tennis match (~75 
minutes), our results may have underestimated the CBT that would be attained towards 
the end of the matches.
Skin temperature responses were similar between SCI and non-SCI players. As Tsk is largely 
related to the ambient temperature, no group differences were expected.19 Furthermore, 
any differences between both groups in upper and lower body Tsk responses would have 
likely resulted from the inability to vasodilate or sweat below the lesion level in the SCI 
players. Previous studies demonstrated that lower body Tsk increases during prolonged 
(90-minute) upper body exercise as a result of increased heat storage in that region.9 20 
Whilst both heat load as well as exercise duration during the present study were limited, 
this may explain lack of pronounced Tsk responses in the SCI and non-SCI group.
Our study had some limitations. An obvious limitation of our study is the low number 
of subjects, which makes it difficult to draw strong conclusions about the actual risk of 
heat stress that the SCI players are subjected to during a match. Further research with 
larger sample-sized should be performed to gain a better insight in the thermal stress 
that wheelchair players are exposed to and the associated risks for developing heat illness 
including collapse and heat stroke.
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In conclusion, we provide some evidence for a larger increase in CBT in SCI wheelchair 
tennis players compared to non-SCI players whilst playing a 45-minute tennis match in 
moderate ambient conditions. This finding suggests that SCI players may have an elevated 
risk to develop heat illness, particularly under hot ambient conditions. We believe that our 
findings warrant future studies to specifically examine the thermoregulatory responses in 
SCI wheelchair tennis players, but also highlight the development of countermeasures to 
prevent hyperthermia.
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Abstrac t
Objectives: Exercise induces changes in haemostatic parameters and core body 
temperature (CBT). We aimed to assess whether exercise-induced elevations in CBT 
induce pro-thrombotic changes in a dose-dependent manner. 
Design: Observational study.
Methods: CBT and haemostatic responses were measured in 62 participants of a 15-km 
road race at baseline and immediately after finishing. As haemostasis assays are routinely 
performed at 37°C, we corrected the assay temperature for the individual’s actual CBT at 
baseline and finish in a subgroup of n=25.
Results: All subjects (44±11 years, 69% male) completed the race at a speed of 12.1±1.8 
km/h. CBT increased significantly from 37.6±0.4°C to 39.4±0.8°C (p<0.001). Post-exercise, 
haemostatic activity was increased, as expressed by accelerated thrombin generation and 
an attenuated plasmin response. Synchronizing assay temperature to the subjects’ actual 
CBT resulted in additional differences and stronger acceleration of thrombin generation 
parameters.
Conclusions: This study demonstrates that exercise induces a prothrombotic state, 
which might be partially dependent on the magnitude of the exercise-induced CBT rise. 
Synchronizing the assay temperature to approximate the subject’s CBT is essential to obtain 
more accurate insight in the haemostatic balance during thermoregulatory challenging 
situations. Finally, this study shows that short-lasting exposure to a CBT of 41.2°C does 
not result in clinical symptoms of severe coagulation. We therefore hypothesize that 
prolonged exposure to a high CBT or an individual-specific CBT threshold needs to be 
exceeded before derailment of the haemostatic balance occurs.
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I ntroduc tion
Strenuous exercise induces a hypercoagulable state, hallmarked by an increased factor 
VIII concentration and a subsequently increased (in vitro) thrombin generation.1-3 
The increased thrombin enables fibrin formation, which stabilizes the platelet plug.4 
Simultaneous to these prothrombotic changes, increased levels of tissue plasminogen 
activator and reduced levels of plasminogen activator inhibitor hallmark increased 
fibrinolysis.1 3 4 In this manner, the prothrombotic effects of exercise are offset by increased 
fibrinolysis, which prevents the formation of excess blood clots. Whilst the magnitude of 
these haemostatic changes are generally well balanced during general aerobic exercise, 
they are associated with an increased risk of cardiovascular complications such as acute 
coronary syndrome in individuals with previous cardiovascular disease.5
In addition to prothrombotic changes, exercise also leads to an increase in core body 
temperature (CBT).6 7 Whilst this exercise-induced CBT increase is a normal result of 
metabolic heat production,8 excessive increases in CBT to values above 40°C can 
potentially result in heatstroke.6 9 10 Heatstroke is characterized by neurological symptoms 
(delirium, coma) and a derailed haemostatic response that results in a disease state similar 
to diffuse intravascular coagulation.9-11 Potential consequences of heatstroke are multi-
organ failure, in part due to thrombotic complications, and may result in death.9 Hence, 
strong CBT rises during exercise bear the risk of developing potential serious thrombotic 
complications. Conversely, hypothermia (a CBT <35°C) has been shown to negatively 
impact on haemostatic activity, resulting in an increased bleeding diathesis.12 13 These 
observations suggest that CBT directly impacts on the activity of the haemostatic system, 
and the procoagulant responses during exercise could thus theoretically be partly caused 
by an increased CBT. However, whether an increased CBT during exercise actually induces 
prothrombotic changes in a dose-dependent manner is currently unknown.
Therefore, the first aim of this study was to investigate whether the exercise-induced 
elevation in CBT induces prothrombotic changes in a dose-dependent manner. To that 
end, we measured thermal and haemostatic responses in 62 participants of a 15-km road 
race at baseline and immediately after finishing. 
Interestingly, haemostatic assays are routinely performed at a temperature of 37°C, whilst 
the in vivo CBT in the present study population was expected to be substantially higher 
(≥ 39.0°C) at the finish line.7 Routinely obtained haemostasis data might thus provide 
inaccurate information due to potentially changing properties of the clotting factors at 
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elevated temperatures.14-16 Therefore, as a second aim, we corrected the temperature at 
which the assay is performed to approximate the subjects’ actual CBT at baseline and after 
finishing in a subgroup of 25 individuals and investigated whether this leads to different 
results compared to the routine assessment at 37°C. We hypothesized that an increased 
CBT at the finish line would enhance prothrombotic responses, and that adjusting the 
temperature at which the haemostasis assay is performed to approximate the subjects’ 
actual CBT would show a more pronounced haemostatic activation.
M ethods
Sixty-two individuals (43 males, 19 females; age 44±11 years; height 178±8 cm; body 
weight 72.8±10.5 kg; body mass index 22.9±2.3 kg/m2) who participated in a 15-km road 
race (Seven Hills Run, Nijmegen, the Netherlands) were recruited for the present study. 
Recruitment took place identically as previously described by the present authors.7 
Before being included in the present study, all subjects provided a written informed 
consent and all subjects were screened for the presence of any exclusion criteria for 
using the temperature pill: 1. A history of obstructive or inflammatory bowel disease or 
prior abdominal surgery, 2. The presence of any implanted electric (medical) device, 3. A 
scheduled MRI scan within 1 week after the event, or 4. Pregnancy. None of the subjects 
had a history of cardiovascular or thrombotic disease, none of the subjects used any 
anticoagulant medication. The average training status of our subjects was 3.6±2.1 hours 
of running exercise per week for the past year. Study procedures were approved by the 
Radboud university medical center Ethics Committee and accorded to the principles of 
the declaration of Helsinki.
Baseline measurements were performed 2 hours before the start of the race in a laboratory 
set up 50 meters from the start/finish line. CBT was measured at baseline, 1 minute before 
the start, and within 15-seconds after finishing. Venous blood samples were obtained via 
venipuncture from an antecubital vein at baseline and within 5 minutes after finishing. 
No measurements were performed during exercise, and subjects completed the race at a 
self-selected pace. Body weight was measured at baseline and immediately after finishing 
(Seca 888, Hamburg, Germany), and relative changes in body weight were calculated to 
determine the hydration status of participants. Dehydration was defined as a body weight 
loss ≥2%.17
Subjects ingested an individually calibrated telemetric temperature pill at least five hours 
(8 a.m.) before the race (start 1 p.m.) to prevent interaction of the CBT measurements with 
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fluid ingestion during testing.18 CBT was measured using a portable telemetry system 
(CorTemp™ system, HQ Inc., Palmetto, USA), which has been demonstrated to safely and 
reliably measure CBT.19 20 The average of three consecutive measurements for each time 
point was used for further analyses. 
Based on finish CBT, subjects were classified as low- (CBT <39) moderate- (39≥ finish CBT 
<40) or high-responders (CBT ≥40). The exercise-induced increase in CBT (ΔCBT) was 
calculated by subtracting baseline CBT from finish CBT. Again, three subgroups were 
created to classify low- (ΔCBT < 1.5) moderate- (1.5≥ ΔCBT <2.5) and high-responders 
(ΔCBT ≥2.5).
Venous blood samples were collected from an anticubital vein in CTAD (sodium citrate 
theophylline, adenosine dypyridamol) buffered collection tubes in our on-site laboratory. 
Samples were centrifuged at 4200 rpm for 15 minutes, after which the plasma was 
immediately transferred into new uncoated Eppendorf tubes which were subsequently 
snap frozen in liquid nitrogen and stored at -80°C until further analysis. Thrombin and 
plasmin generation were simultaneously measured using the ‘Nijmegen Haemostasis 
Assay’.21 This assay allows simultaneous measurement of in vitro thrombin and plasmin 
generation in the same blood specimen in a single well (Figure 6-1). Lag time thrombin 
generation describes the lag time between activation of the coagulation cascade and 
the time at which the initiation of thrombin generation is measured. Time to thrombin 
peak refers to the time between activation of the coagulation cascade and reaching the 
peak thrombin generation value. Thrombin peak height refers to the maximal thrombin 
generation rate. The area under the curve reflects the total thrombin potential (AUC
thrombin
). 
Plasmin peak time refers to the time between activation of the coagulation cascade and 
the time at which the plasmin peak is reached. Plasmin peak height refers to the maximal 
plasmin generation rate. Fibrin lysis time refers to the time between the start of plasmin 
generation and the moment at which plasmin peak height is attained. In all instances, 
each plasma sample was analysed in duplicate and the average of each duplicate was 
used for further analysis. The inter-assay variation of thrombin generation parameters 
varies from 5.9% (AUC
thrombin
) to 25% (lag time thrombin generation). The inter-assay 
variation of plasmin generation parameters varies from 10% (plasmin peak height) to 14% 
(plasmin potential).
For aim 2, we re-analysed the plasma samples at an assay temperature nearest to the 
subject’s CBT at baseline and finish in a subgroup of n=25. For example, if a subject had a 
baseline CBT of 37.4°C, the assay was performed at 37°C, whereas in case of a baseline CBT 
of ≥37.5°C and ≤38.4°C the assay was performed at 38°C. Likewise, a finish CBT of 39.4°C 
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was analysed at an assay temperature of 39°C and finish CBT ≥39.5°C at 40°C. Within this 
subgroup we also measured additional haemostatic parameters, in order to quantify the 
in vivo haemostatic activity. Plasma prothrombin fragment 1+2 was measured to assess 
the in vivo thrombin generation using an enzyme-linked immunosorbent assay (ELISA; 
Enzygnost F1+2, Behring Diagnostics GmbH, Frankfurt, Germany), while plasma D-dimer 
levels were measured to quantify the in vivo fibrinolysis activity using an ELISA (Zymutest 
D-dimer, Hyphen BioMed, Neuville-sur-Oise, France). Furthermore, we determined the 
isolated effect of the assay temperature on haemostasis parameters by performing the 
analyses at 37°C, 38°C, 39°C and 40°C in the subgroup of n=25.
Statistical analyses were performed using the Statistical Package for the Social Sciences 
(IBM SPSS Statistics for Windows, Version 20.0, IBM Corp., Armonk, NY, USA). Data were 
reported as mean ± standard deviation unless otherwise indicated. All haemostasis data 
were visually inspected for normality distribution. In case of a non-Gaussian distribution, 
log-transformation was performed and data were re-inspected. If a normal distribution 
could not be attained, non-parametric analyses were performed. The impact of exercise 
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Figure 6-1: Schematic	 overview	 of	 the	 Nijmegen	 Haemostasis	 Assay.	 The	 dotted	 line	 represents	 real-time	
measurement	 of	 thrombin	 generation,	 whilst	 the	 continuous	 line	 represents	 the	 simultaneous	 real-time	
measurement	of	plasmin	generation	 in	the	same	blood	sample.	For	the	purposes	of	the	present	study,	 four	
parameters	 were	 derived	 from	 thrombin	 generation:	 (1)	 Lag	 Time	 Thrombin	 Generation	 (min),	 (2)	 Time	 to	
Thrombin	 Peak	 (min),	 (3)	 Thrombin	 Peak	 Height	 (nmol/L)	 and	 (4)	 AUC
thrombin
	 (nmol/L/min).	 From	 plasmin	
generation,	three	parameters	were	derived:	(5)	Plasmin	Peak	Time	(min),	(6)	Plasmin	Peak	Height	(nmol/L)	and	
(7)	Fibrin	lysis	time	(min).	Adapted	from	Van	Geffen	et	al.	(2011).21
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on changes in haemostatic parameters was assessed using a paired Student’s T-Test. 
To test the hypothesis that a higher finish CBT would aggravate the exercise-induced 
haemostatic responses two-way repeated measurements analysis of variance (Gaussian 
distributed data) and Kruskal-Wallis or Friedman test (non-Gaussian distributed data) were 
used. The relationship between finish CBT and post-exercise haemostasis parameters was 
calculated using a Pearson (Gaussian distributed data) or Spearman’s rank correlations 
(non-Gaussian distributed data).
Results
All subjects completed the race in cool environmental conditions (Wet bulb globe 
temperature 12.5°C, Dry-Bulb temperature 10.5°C, relative humidity 87%, wind speed 3.4 
– 5.4 m/s) at an average running speed of 12.1±1.8 km/h. The average body weight loss 
during the race was -1.4±0.6% of total body weight, and 18% of all subjects classified as 
dehydrated. Post-exercise, lag time in thrombin generation (baseline 4.5±1.1 versus finish 
3.8±0.7 min; p<0.001) and time to thrombin peak (9.0±1.4 vs. 8.0±0.9 min; p<0.001) were 
significantly shortened, whilst thrombin peak height (207±29 vs. 208±25 nmol/L; p=0.70) 
and AUC
thrombin
 (1293±172 vs. 1292±172 nmol/L/min; p=0.94) did not differ between 
baseline and post-exercise. Plasmin peak time (36.6±9.1 vs. 35.3±8.2 min; p=0.20) and 
fibrin lysis time (30.6±8.6 vs. 30.4±8.3 min; p=0.81) did not change after exercise, whereas 
a significant reduction in plasmin peak height (19.2±12.2 vs. 10.0±9.0 nmol/L; Wilcoxon 
Signed Ranks Test p<0.001) was observed after finishing.
Baseline CBT was 37.6±0.4°C and increased significantly (1.8±0.9°C, p<0.001) to 39.4±0.8°C 
at the finish line (range: 38.0–41.2°C). We identified 24 low-responders, 20 moderate-
responders and 18 high-responders for finish CBT. Coagulation and fibrinolysis responses 
did not differ across low-, moderate- and high-responders for all but one parameter (Table 
6-1). A group effect (p<0.02) was found for AUC
thrombin
, with significantly higher values in 
moderate- and high-CBT responders compared to low-CBT responders. Similarly, the 
magnitude of ΔCBT did not interact with changes in haemostatic parameters (Table 6-2). 
Lastly, neither finish-CBT nor ΔCBT correlated significantly with post-exercise haemostasis 
parameters, body weight loss or running speed (Table 6-3).
Synchronisation of the haemostatic assay temperature to actual baseline and finish CBT 
resulted in a significant decrease of lag time thrombin generation, time to thrombin 
peak, thrombin peak height and AUC
thrombin
 between baseline and finish (Figure 6-2A-D 
respectively). Plasmin peak time synchronized to actual CBT and plasmin peak height 
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Figure 6-2: Results	of	the	routinely	performed	assays	(left	hand	side	of	graph)	versus	the	assay	results	corrected	
for	the	actual	core	body	temperature	(right	hand	side	of	graph)	at	baseline	and	post-finish	(black	and	grey	bars	
respectively).	All	corrected	results	for	the	baseline	samples	were	corrected	for	CBT	at	baseline,	and	all	corrected	
results	for	the	finish	samples	were	corrected	for	CBT	at	the	finish	line.	(A)	Lag	Time	Thrombin	Generation;	(B)	
Time	to	Thrombin	Peak;	(C)	Thrombin	Peak	Height;	 (D)	AUC
thrombin
;	(E)	Plasmin	Peak	Time;	(F)	Plasmin	Peak	
Height;	(G)	Fibrin	Lysis	Time.	Legend:	#	=	p<0.05;	†	=	p<0.01;	‡	=	p<0.001;	*	=	Statistics	are	based	on	non-
parametric	analysis.	Data	are	presented	as	mean	±	standard	error	of	the	mean.	CBT	=	Core	Body	Temperature
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decreased significantly between baseline and finish (Figure 6-2E + F), whilst fibrin lysis 
time did not change significantly (Figure 6-2G). Interestingly, a high finish CBT resulted 
in a prolonged fibrin lysis time, which was in contrast with subjects that reported a 
moderate and low finish CBT and demonstrated a shorter fibrin lysis time (Table 6-4). In 
addition, fragment 1+2 increased from 223±121 pmol/L to 482±623 pmol/L (p<0.001), 
while d-dimer increased from 247±128 ng/L to 1223±2821 ng/L (p<0.001). No correlation 
was found between the change in Fragment 1+2 and finish CBT (r=-0.01; p=0.96) or the 
change in d-dimer and finish CBT (r=0.04; p=0.87). A similar effect of assay temperature 
on haemostasis parameters was observed in the subgroup analyses of n=25 (Table 6-5).
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Discussion
The purpose of this study was to investigate whether the exercise-induced CBT-rise 
causes prothrombotic changes in a dose-dependent manner, and whether correcting 
the temperature at which the haemostasis assay is performed to approximate the 
subjects’ actual CBT alters the haemostasis outcomes. Our study demonstrates that 
thrombin generation peaked significantly earlier after the race compared to baseline 
and that plasmin peak height was significantly lower after finishing. However, changes 
in haemostatic parameters were not related to finish CBT or ΔCBT.  The novelty of our 
findings lies in the adjustment of the assay temperatures to approximate the subjects’ 
CBT. Correcting the assay temperature resulted in more pronounced changes of time 
to thrombin peak and AUC
thrombin
, and resulted in the additional identification of a 
significantly shortened lag time thrombin generation, decreased thrombin peak height 
and a significant impact of finish CBT on fibrin lysis time. These results suggest that 
increases in CBT may partially contribute to the exercise-induced haemostatic activation, 
but that (short lasting) exposure to CBTs up to 41.2°C does not result in clinical symptoms 
of increased coagulation. Hence, prolonged exposure or a higher CBT is needed to induce 
excessive coagulation that is typically observed in athletes diagnosed with heatstroke. 
Most importantly, our results demonstrate that synchronization of the temperature at 
which haemostasis assays are performed significantly influences the results. In situations 
where CBT is outside of normal (36.0 – 37.5°C) range, it is essential to adjust the assay 
temperature to obtain the most accurate results.
Participants of our study demonstrated a large (1.8±0.9°C) and significant increase in 
CBT after running a 15 km road race, with an average finish CBT of 39.4±0.8°C. These 
thermoregulatory responses are in agreement with a previous study.7 Our subjects were 
well trained (3.6±2.1 hrs/week) and were thus well accustomed to the elevated CBT caused 
by the exercise itself. We also observed a significant activation of the haemostatic balance, 
as expressed by a faster thrombin generation and an attenuated plasmin response. These 
findings confirm the prothrombotic effects of exercise that were reported previously.4 
5 22 Since prolonged endurance training has previously been shown to attenuate the 
prothrombotic effects of exercise,23 our findings might have been more pronounced in an 
untrained control group. Independent of training status, the combination of a large inter-
individual variation in CBT with a significant haemostatic activation allows us to explore 
the potential relationship between these exercise-induced phenomena.
Haemostatic responses were largely comparable between low, moderate and high 
responders of finish CBT. Although the AUC
thrombin
 was significantly higher in moderate- and 
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high-responders compared to low-responders, the other exercise-induced haemostatic 
changes did not differ across finish-CBT groups. In contrast to our hypothesis, these data 
suggest that the exercise-induced pro-thrombotic changes do not depend on finish CBT. 
The observation of a massive haemostatic activation in patients with heatstroke suggests 
that excessive thrombotic responses may only occur above a certain CBT threshold or 
after prolonged exposure to a high CBT.24 25 Hence, the peak finish CBT that was reported 
in our study (41.2°C) was apparently either too low to induce substantial activation of 
the coagulation cascade, or too short lasting to induce substantial changes. Data from 
several animal studies reinforced this hypothesis and showed that prolonged (2.5 - 3 
hours) passive heating with a CBT >42°C was needed to induce excessive activation of the 
haemostatic response.11 26 27 Indeed, the finish CBTs that were observed in our subjects did 
not result in a derailed haemostatic response nor in clinical symptoms. This was supported 
by the statistically significant, though clinically irrelevant, increase in plasma prothrombin 
fragment 1+2 and d-dimer levels in absence of a correlation of these parameters with 
finish CBT. Therefore, physical exercise typically performed by the general population 
does not necessarily result in a derailment of blood haemostasis.
Importantly, the absence of an interaction between CBT and haemostasis may relate to 
the fact that analyses were performed at 37°C instead of the actual CBT at the time of 
blood collection. When synchronizing the assay temperature to the individuals’ baseline 
and finish CBT, we observed additional and stronger baseline-to-finish changes in several 
haemostatic parameters compared to the findings from the assay at 37°C (Figure 6-2). 
Differences were not limited to finish results, but also showed altered baseline values 
when synchronizing for baseline CBT. Athletes with a finish CBT ≥40.0°C demonstrated 
a significantly larger fibrin lysis time compared to peers with a lower finish CBT who 
demonstrated a reduced fibrin lysis time. These findings were confirmed by the analysis 
in which we varied the assay temperature (Table 6-5) and suggest a direct impact of CBT 
on exercise-induced haemostatic responses. Interestingly, we have observed this effect 
after analysis of frozen plasma samples which had already been exposed once in vivo to 
an elevated temperature during the exercise bout. The fact that we were able to identify 
additional significant changes or stronger baseline-to-finish changes compared to when 
the assays were performed routinely at 37°C suggests that at least part of the observed 
procoagulant effects are temperature-dependent. Evidence from previous studies in 
hypothermic patients support our observations. These studies showed that lowering 
the haemostatic assay temperature to mimic the real-life CBT resulted in a prolonged 
initiation of blood clotting, whilst the absolute concentration of clotting factors remained 
unchanged.15 28 29 Altogether, these data suggest that altering the CBT causes the 
enzymatic coagulation reaction to become slower at lower temperatures versus faster at 
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higher temperatures.29 Our findings therefore demonstrate that it is essential to adjust the 
assay temperature to approximate the subject’s CBT in order to obtain the most accurate 
results. This may not only apply to exercise-induced CBT rises, but also to other conditions 
where CBT is outside of the normal physiological range.
We found that running a 15 km road race resulted in a pro-coagulant state, which is 
partially dependent on the magnitude of the exercise-induced rise in CBT. None of our 
subjects experienced clinical coagulation-related problems, which indicates that changes 
in haemostatic parameters that are accompanied by a CBT up to 41.2°C are of minor clinical 
relevance. Hence, our data suggest that heatstroke-induced disseminated intravascular 
coagulation, which is a serious threat for endurance athletes,30 occurs when CBT passes 
a certain threshold value. Once an athlete exceeds this threshold and is diagnosed with 
heatstroke, our data underline the importance of rapid and aggressive cooling, which 
may reduce the CBT related stimulation of the coagulation cascade and could result in 
a better outcome. Notably, given the diverse range of peak core body temperatures that 
individuals develop during exercise,7 this CBT threshold might be individually determined.
A potential limitation of the present study is that blood samples were collected within 5 
minutes after finishing, while CBT was assessed directly at the finish line. Due to the time 
difference, subjects may have had a slightly lower CBT at the time of blood collection 
due to passive cooling. Nevertheless, it is unlikely that these minor CBT differences would 
impacted our haemostasis results, apart from the fact that it would even underestimate 
our findings. Another potential limitation of the present study is that we did not correct 
for exercise-induced changes in plasma volume. However, 82% of our study population 
was well hydrated, making it unlikely that shifts in plasma volume had a large impact 
on study outcomes. Importantly, all measurements for the temperature adjusted assays 
were performed on the same plasma samples and the only manipulated factor was 
assay temperature. Therefore, the adjusted assay temperature data were not affected 
by plasma volume changes. Lastly, whilst the applied haemostasis assay has a low inter-
assay variability for analyses performed on a single say, the variability is slightly larger 
when comparing analyses performed on separate days (for example Table 6-1 versus Table 
6-5). All results reported within each table were therefore acquired on a single day and all 
reported results can thus be safely interpreted within each table. However, even though 
the assay variability when performed on separate days was limited, caution should be 
applied when comparing several tables with one another.
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Conclusion
In conclusion, this study demonstrates that exercise induces a procoagulant state, and 
our results suggest that this might partially be dependent on the magnitude of the 
exercise-induced CBT rise. Moreover, athletes with a finish CBT as high as 41.2°C do 
not necessarily demonstrate haemostatic activation leading to clinical symptoms. We 
therefore hypothesize that prolonged exposure to, or a specific CBT threshold needs to 
be exceeded before derailment of the haemostatic balance occurs. Most importantly, our 
results show that adjusting the assay temperature to approximate the subject’s CBT is 
highly recommended to obtain more accurate insight in the haemostatic balance when 
CBT lies outside the physiological range.
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The aim of this thesis was to further explore general thermoregulatory responses during 
exercise in a heterogeneous population and to identify which factors contribute to the 
magnitude of the core body temperature rise during exercise. This thesis was partly in-
spired by a personal experience during my medical training whilst performing a rotation 
in the Emergency Department in the Jeroen Bosch Hospital, Den Bosch. Whilst heat-
stroke is a rare phenomenon in the Netherlands, I encountered the following case.
Case Repor t
A 36-year old male army recruit was rushed into the emergency room following acute 
collapse during a training exercise. He was participating in a ‘speed march’, in which 
recruits had to complete a 7-km march as fast as possible whilst wearing full military 
outfit and gear comprising at least 10, but in practise 15kg of extra weight. The march was 
conducted during spring time on one of the first warm days of the year, with clear skies 
and an ambient temperature of 27°C. After marching 5-km, the recruit suddenly collapsed 
and the emergency services were called in.
Upon arrival of the paramedics, the patient was unresponsive, tachypneic (>30/min) and 
slightly hypoxic (O2 saturation 93%). In addition, he was tachycardic (170 BPM), hypotensive 
(80/40mmHg), and hyperthermic (auricular temperature 40.9°C). The patient was 
stabilized for transport by immediate administration of oxygen, fast infusion of unheated 
IV fluids and commencement of external body cooling using drenched towels and water. 
Upon arrival to the emergency ward, the patient was responsive to verbal stimulation, 
but was still tachypneic (>30/min), and showed slight improvement of haemodynamic 
functions (heart rate 150 BPM, blood pressure 97/50mmHg) with a rectal temperature of 
40.6°C. Initial laboratory workup showed a slightly reduced kidney function (serum-urea: 
9.9 µmol/L, creatinine: 146 µmol/L, glomerular filtration rate (MDRD): 47mL/min/1.73 
m2) but was otherwise unremarkable. Treatment with external cooling and IV fluids was 
continued until the patient’s vital functions normalized and he had a rectal temperature 
of ≤38.0°C. The patient was observed for several days, and was discharged after complete 
resolution of all symptoms. He made a full recovery.
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H yper thermia:  New Definit ions Needed
This case report of a heatstroke patient demonstrates the fine line between clinically 
relevant and irrelevant hyperthermia. Our recruit got into severe physical problems 
at a core body temperature of 40.6 – 40.9°C during strenuous exercise – which was 
presumably even higher at the time of collapse given the delayed measurements. In 
contrast, 15% of our test subjects in Chapter 2 also developed a core body temperature 
≥40.0°C whilst performing strenuous high intensity exercise, however none of them had 
any physical symptoms. Whilst a multitude of factors (e.g. environmental conditions, 
clothing, acclimatization state, exercise intensity, etc.) distinguishes both cases, core body 
temperature was similar. These observations open up a new discussion on whether the 
term ‘exertional hyperthermia’ – i.e. a core body temperature above 40.0°C – is appropriate 
and clinically relevant.
Current literature defines ‘exertional hyperthermia’ as ‘a core body temperature higher 
than 40.0°C during physical exercise’.1 This definition implies that some degree of core 
body temperature rise during exercise falls within the normal physiological range, but that 
excessive rises will cause physical problems. The dichotomous and arbitrary threshold of 
40.0°C is largely based on reports about heatstroke which underline that high core body 
temperatures can lead to heat illness.2-6 However, as shown in Chapter 2 of this thesis and 
other literature, many individuals sustain core body temperatures that approach or even 
exceed the threshold of exertional hyperthermia without developing any symptoms.7-9 
Hence, it can be questioned whether the term ‘exertional hyperthermia’ is clinically 
relevant in absence of symptoms. In contrast, subjects may already suffer symptoms such 
as syncope or heat exhaustion well before they develop core body temperatures higher 
than 40.0°C whilst other individuals might be better tolerant to the same conditions.1 
Importantly, ‘hyperthermia’ can also be defined as a ‘core body temperature that is higher 
than the hypothalamic set-point’, or in other words an increased core body temperature 
due to inadequate thermoregulatory measures.2 10 Therefore, it would seem more prudent 
to speak of hyperthermia in any case where thermoregulatory measures fail and core 
body temperature rises above the assumed thermoregulatory setpoint. To account for 
the high individual variability of heat tolerance, further definition of hyperthermia as 
‘symptomatic’ or ‘asymptomatic hyperthermia’ would be more meaningful to distinguish 
clinically relevant from irrelevant hyperthermia.
Chapter 7106   |
Symptomatic  ve r s u s  Asymptomatic  H yper thermia:  A  Role 
for  Time of  Exposure?
So why did none of the subjects in this thesis develop symptomatic hyperthermia, even 
though as much as 15% developed core body temperatures higher than 40°C? Part of the 
explanation might be due to the fact that it is unknown for how long our subjects were 
exposed to the extreme core body temperatures, but that the time of exposure was likely 
limited. Interestingly, a Middle East based research group previously performed several 
studies to investigate the pathogenesis and potential treatment of heatstroke using a 
baboon model.11-16 In their model, the baboons needed to be heated in an incubator for 
several hours before heatstroke occurred. Although the mode of heating was different 
from our own subjects (passive external heating versus active heating through muscle 
labour), the results of Bouchama et al. show that prolonged exposure is necessary to 
induce health problems. Therefore, our subjects may not have been exposed to high 
core body temperatures long enough to develop any symptoms. In addition, tolerance 
to exercise in hot ambient conditions has been shown to be directly linked to both skin 
blood flow capacity and skin temperature irrespective of core body temperature.17-19 
Even more, skin temperature itself has been suggested to have a greater impact on 
thermoregulation than core body temperature.19-22 Effectively, this means that so long as 
there is ample capacity to cool excess body heat via the skin – i.e. when skin temperature 
is low or there is still capacity to further perfuse the skin with core-heated blood – any 
heat-related symptoms or performance decrements are mitigated by the more efficient 
cooling. Although we did not measure skin temperature in our subjects, the cool ambient 
conditions in our studies have likely helped keep our subjects’ skin temperature low. This 
would have allowed them to better tolerate their elevated core body temperatures and 
keep them from developing any heat-related symptoms. Other factors that might have 
prevented our subjects from developing heat-related symptoms likely include good 
training status and high fitness level23-26 and no influence by a poor acclimatization state 
given the cool ambient conditions in which all measurements were performed.23 24 26
Predic tabi l i t y  of  Thermoregulator y Responses
Whilst previous literature agrees on several risk factors for developing heat illness, it is 
still difficult to predict which athletes will become severely hyperthermic and which 
athletes will only show modest increases of core body temperature. In Chapters 2 and 3, 
our predictive model for peak core body temperature was shown to have a predictive 
capacity of 32%.27 28 A large part of the model includes previous data of the individuals’ 
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thermoregulatory responses, accounting for as much as 25% of peak core body 
temperature during a 15-km road race.28 These results suggest that a large part of the 
thermoregulatory responses during exercise are individually determined irrespective 
of external factors such as ambient conditions. This is further supported by evidence 
showing that a previous episode of heat illness increases the risk of a repeat event.1 29 
30 The individuality of thermoregulatory responses make a general risk assessment 
for extreme hyperthermia very difficult, and the findings of this thesis warrant a more 
individualistic approach. Factors to include into a predictive model for hyperthermia 
should include age, body mass index and fluid intake before commencement of exercise, 
but the model preferably also includes previous data from the individual including core 
body temperature rise during warming-up and a previous peak core body temperature. 
To make more accurate assessments, future studies should further investigate additional 
individual factors contributing to the thermoregulatory response during exercise. Whether 
hyperthermia becomes symptomatic or not likely depends on other (previously reported) 
risk factors including sleep deprivation, recent febrile illness, poor acclimatization 
state, medication use (diuretics and antidepressants amongst others), dehydration and 
clothing.1 3 4 30 31
Early identification of individuals who are at risk of developing extremely high core body 
temperatures (e.g. ≥40.0°C) can help identify those athletes who might benefit most from 
early (pre-) cooling interventions. Especially in hot environmental conditions, (continuous) 
monitoring of such individuals may help prevent the onset or limit the severity of 
symptomatic hyperthermia. When considering that a high core body temperature could 
attenuate exercise performance,24 32 identifying the athletes who are most likely to develop 
the highest core body temperatures could help decide which athletes will benefit most 
from pre- or even precooling (i.e. cooling during exercise) to maintain or even boost their 
performance levels.33-35
M echanism and Cytok ines  I nvolved in  Exercise - I nduced 
H yper thermia
For several years it has been known that exercise induces the release of pro-inflammatory 
cytokines.36-40 Whilst the exact mechanism between exercise and cytokine release is still 
unknown, it has been demonstrated that both prolongation of exercise as well as higher 
intensity of exercise induce a stronger cytokine release compared to relatively light and 
short-lasting exercise.37-39 41-43 Hence, the mechanism of cytokine release is likely due to the 
sustained microtrauma in the exercising muscle, which causes local inflammation as part 
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of the tissue repair process.44 Based on this information, we hypothesized that the release 
of inflammatory cytokines could upregulate the hypothalamic temperature setpoint in 
the same manner as during fever and we found evidence supporting this hypothesis. So 
which cytokines could be responsible for the upregulated hypothalamic setpoint during 
exercise?
As mentioned in Chapter 4, interleukin-6 and interleukin-1 play a central role in any 
inflammatory response, and are known to be released during exercise.36-39 Whilst they 
stimulate the release of prostaglandin E
2
, they have also been shown to directly upregulate 
the temperature setpoint itself, independent of prostaglandins.45 Since only prostaglandin 
production was blocked in Chapter 4, the direct effect of the cytokines during exercise was 
not taken into consideration and has likely led to an underestimation of the true cytokine 
effect. Future studies should therefore further explore the direct impact of these cytokines 
on the hypothalamic temperature setpoint during exercise by applying interleukin-6 and 
interleukin-1 blockers. Another potential target cytokines could be tumor necrosis factor 
α, which is also known to be released during exercise.39 42 43 Lastly, a potential but important 
other cause of pro-inflammatory cytokinaemia is endotoxaemia due to increased intestinal 
cellular permeability. Prolonged exercise leads to a dramatic redistribution of blood flow, 
with a restricted gastrointestinal blood flow of up to 80%. The resulting (mild) intestinal 
ischemic state causes cellular damage and induces endothelial leakage, resulting in the 
introduction of bacterial lipopolysaccharide (LPS) into the blood stream producing a 
response similar to systemic inflammatory response syndrome (SIRS).24 46 47 Paradoxically, 
a potentially aggravating factor is the increased core body temperature caused by the 
exercise itself, which may lead to further intestinal cellular damage which could even 
further aggravate the cellular leakage.24 47 Future studies investigating the interaction 
between the immune system and thermoregulation during exercise might therefore 
also consider endotoxaemia as an indirect causal factor for the increased hypothalamic 
setpoint.Taking these new insights into account, the schematic overview of human 
thermoregulation that was presented in Chapter 1 can be expanded as shown in Figure 
7-1. Based on our findings the release of pro-inflammatory cytokines during exercise leads 
to an upregulated hypothalamic temperature setpoint. This alternative mechanism is 
likely partially responsible for the increased core body temperature during exercise, with 
metabolic heat production due to muscle labour still being the major determining factor 
of core body temperature during exercise.
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Why Does H yper thermia I ncrease Haemostatic  Ac t ivit y?
As evidenced by previous literature, symptomatic hyperthermia in its most dramatic form 
of heatstroke can result in massive activation of the coagulation cascade.2 11 15 Chapter 5 
demonstrated that exercise itself leads to procoagulant changes,44 48-50 whereas a part of the 
procoagulant changes might be directly related to the increased core body temperature 
itself. Interestingly, we found these changes by modifying the environmental temperature 
of the haemostasis assay by analysing plasma samples that had already been frozen. The 
fact that we sill found a temperature effect even though the samples had previously been 
frozen suggests that the temperature effect is reversible. But why would the physiologic 
process of increased haemostasis under increased core body temperatures be beneficial 
for survival? From an evolutionary viewpoint, hunting for food or fleeing from danger 
carried a risk of being wounded and being subjected to potentially fatal bleeding. 
A haemostatic balance that is pushed toward a hypercoagulable state before being 
wounded would be favourable since a shortened bleeding time would reduce blood loss 
and thus increase survival.
In addition to limiting blood loss due to a potential injury, temperature-induced 
hypercoagulability is also favourable in everyday life when fighting infection. The 
myriad of pro-inflammatory cytokines that are released during infection play an intricate 
interaction with the coagulation cascade and also push the haemostatic balance towards 
hypercoagulability.51-55 At the site of infection, the immune system tries to combat the 
pathogen by either destroying infected tissue or by directly attacking the pathogen itself. 
In this process, thrombi are formed at the site of infection to encapsulate the diseased tissue 
and pathogens, in order to limit further tissue damage and prevent further dissemination 
of the infection. By pushing the haemostatic balance towards hypercoagulability during 
hyperthermia, or in this case fever, augments the influence of the inflammatory cytokines 
to help contain and eliminate the infection.
Future Perspec tive and Cl inical  I mplicat ions
This thesis has produced new insights into the prevalence of hyperthermia during exercise 
and factors that are associated with the stronger rises in core body temperature. It was 
shown that risk assessment for strong core body temperature rises is very individual-
specific but can be partially predicted. Hence, individuals who are most at risk of the 
strongest core body temperature rises can be identified beforehand and, if desired, be 
monitored more closely during exercise. With growing technological innovation over 
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the past years concerning ingestible temperature sensors,56-58 future monitoring likely 
progresses to real-time monitoring of numerous body vitals including core body 
temperature. With growing interest in pre- and percooling strategies (i.e. cooling during 
exercise), real-time monitoring may enable medical staff to better decide when to start 
cooling in order to maintain or even improve performance levels.33-35 Importantly, this 
thesis has shown that hyperthermia during exercise is common and – at least in cool to 
moderate ambient conditions – does not necessarily lead to health problems. Medical 
staff should remain vigilant for the onset of heat-related symptoms, but treatment 
hyperthermia is not immediately necessary in absence of symptoms.
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Summar y
Chapter 1 introduces the general concepts of thermoregulation and maps out how 
exercise can be a burden for thermoregulation by producing heat in excess of heat 
dissipating capabilities. When core body temperature rises, it can cause several health 
problems such as heat exhaustion or syncope, but also lead to more serious health 
issues such as the occurrence of heatstroke. This is a disease state caused by a systemic 
inflammatory response mimicking sepsis and causing hyperactivation of the immune 
system and coagulation. Lastly, an elevated core body temperature can also limit exercise 
performance, either by inducing central fatigue or decreased cardiac output due to blood 
volume depletion, and usually a combination of both. The chapter ends by an outline of 
the thesis.
Chapter 2 aims to assess what core body temperatures are commonly observed after a 15-
km road race and to assess how often exertional hyperthermia (a core body temperature 
≥40.0°C) occurs. Secondly, chapter 2 aims to identify factors that significantly predict the 
rise in core body temperature during exercise and develop a predictive model. Core body 
temperature is measured before the start of the race and immediately after finishing in 227 
volunteers. Core body temperature significantly increased from 37.6±0.4°C at baseline to 
39.2±0.7°C after finishing. The temperature change between baseline and after warming 
up was identified as strongest predictor for core body temperature at the finish line. With 
as much as 15% of all subjects showing exertional hyperthermia at the finish line, the 
findings emphasize that it is a common phenomenon and can be partially predicted.
Chapter 3 aims at further elucidation of the predictability of individual thermoregulatory 
responses during exercise. Data from the same individuals participating in 2 consecutive 
editions of a 15-km road race are correlated. Addition of previously obtained 
thermoregulatory data from the first race edition to the predictive model as described in 
Chapter 2 proved to substantially better predictability of thermoregulatory responses for 
the second race edition, with a 32.2% predictability compared to a 17.1% predictability 
without the historical data.
In Chapter 4 the role of the hypothalamic thermoregulatory setpoint during exercise is 
investigated. Previous literature demonstrated a substantial release of pro-inflammatory 
cytokines during exercise, theoretically causing a fever-like upregulation of the 
hypothalamic setpoint. In this chapter, subjects perform 3 bouts of identical treadmill 
exercise whilst ingesting medication that blocks prostaglandin E
2
 (one of the main 
mediators of setpoint upregulation) production centrally and peripherally, only centrally 
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or not at all. The condition in which both central and peripheral prostaglandin E
2
 blockade 
was applied showed a significantly lower peak core body temperature during the exercise 
bout compared to the control condition. This finding suggests that an upregulated 
hypothalamic setpoint might be partially involved in the core body temperature rise seen 
during exercise.
Chapter 5 comprises a pilot study, which investigates the differences in thermoregulatory 
responses between spinal cord injured and non-spinal cord injured elite wheelchair 
tennis players. A total of eight volunteers (3 spinal cord injured, 5 non-spinal cord injured 
wheelchair tennis players) played a 45-minute match whilst thermoregulatory responses 
including core body temperature and skin temperature were measured continuously. 
The main results show that core body temperature increased stronger in the spinal cord 
injured athletes compared to the non-spinal cord injured athletes, though no statistical 
significance could be calculated on this due to insufficient sample size. These descriptive 
data suggest that spinal cord injured wheelchair tennis players might be at increased risk 
of developing heat related problems during a match, and warrant further research into 
this subject.
Chapter 6 focusses on the potential effects of core body temperature on haemostasis. 
Haemostasis assays are performed in plasma samples obtained in volunteers before and 
immediately after finishing a 15-km road race. The main findings are that exercise induces 
a prothrombotic state, which might be partially dependent on the exercise-induced core 
body temperature rise. Adjusting the assay temperature to match the subject’s actual 
core body temperature at the time of blood collection (which is often substantially higher 
than the standard 37°C which is assumed in routine assays) produced more pronounced 
haemostatic changes after exercise. These findings show that haemostasis is affected by 
exercise-induced core body temperature rise, but also demonstrate the importance of 
synchronizing the haemostasis assay temperature to the subject’s core body temperature 
at the time of sample collection.
Chapter 7 summarizes, discusses and explains the findings of the present thesis. An 
attempt is made to provide future perspective on individual prediction and monitoring, 
and provides the clinical implications of the present findings.
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Hoofdstuk 1 introduceert de algemene concepten van thermoregulatie en zet uiteen hoe 
fysieke inspanning de thermoregulatie nadelig kan beïnvloeden doordat er meer warmte 
wordt geproduceerd dan de afkoelingsmechanismen kunnen afvoeren. Stijging van de 
kerntemperatuur kan leiden tot diverse gezondheidsproblemen, zoals warmte uitputting 
of warmte syncope, maar het kan ook leiden tot ernstigere gezondheidsproblemen 
zoals hitteberoerte. Hitteberoerte is een aandoening welke wordt veroorzaakt door 
een systemische inflammatoire respons die lijkt op sepsis en massale activatie van het 
immuunsysteem en de stollingscascade kan veroorzaken. Ten slotte wordt besproken 
hoe een verhoogde kerntemperatuur ook het prestatievermogen tijdens inspanning kan 
verlagen door enerzijds ‘centrale vermoeidheid’, anderzijds een verlaagde cardiac output 
door bloedvolume depletie, maar meestal een combinatie van beide. Het hoofdstuk 
eindigt met een uiteenzetting van de inhoud van dit proefschrift.
Hoofdstuk 2 heeft als doel te onderzoeken welke kerntemperaturen veelal voorkomen 
na het lopen van een 15-km hardloopwedstrijd, en maakt een inschatting hoe vaak 
inspanningsgebonden hyperthermie (een kerntemperatuur ≥40.0°C) voorkomt. Ten 
tweede heeft dit hoofdstuk als doel factoren te identificeren die de stijging van de 
kerntemperatuur tijdens inspanning significant kunnen voorspellen. Bovendien wordt 
gepoogd hiervoor een voorspellend model te ontwikkelen. Bij 227 vrijwilligers wordt 
de kerntemperatuur gemeten voor de start van de race en direct na het finishen. 
De kerntemperatuur steeg significant van 37.6±0.4°C in rust vóór warming-up naar 
39.2±0.7°C direct na het finishen. De temperatuurstijging tussen de rustmeting en na de 
warming-up bleek de sterkste voorspeller te zijn van de kerntemperatuur op de finish 
lijn.  Van alle proefpersonen bleek 15% op de finish lijn te voldoen aan de criteria voor 
inspanningsgebonden hyperthermie. Deze bevindingen tonen aan dat hyperthermie een 
veel voorkomend fenomeen is, en deels kan worden voorspeld.
Hoofdstuk 3 heeft als doel de voorspelbaarheid van de individuele thermoregulatoire 
respons tijdens inspanning verder in kaart te brengen. Gegevens van een groep vrijwilligers 
die aan twee opvolgende edities van hetzelfde 15-km hardloopevenement meedoen 
worden met elkaar gecorreleerd. Het toevoegen van de thermoregulatoire gegevens uit 
de eerste editie aan het voorspellend model zoals beschreven in hoofdstuk 2 blijkt de 
voorspelbaarheid van de kerntemperatuur op de finish lijn substantieel te verbeteren. Het 
oorspronkelijke model heeft een voorspelbare waarde van 17.1%, terwijl het toevoegen 
van de historische gegevens de voorspelbaarheid verbetert naar 32.2%.
In hoofdstuk 4 wordt de rol van het hypothalame temperatuur setpoint tijdens inspanning 
onderzocht. Voorgaande literatuur beschreef eerder dat er een aanzienlijke hoeveelheid 
pro-inflammatoire cytokines vrijkomt tijdens fysieke inspanning. In theorie kan dit een 
respons veroorzaken welke lijkt op een koortsreactie en hierdoor het hypothalame 
setpoint verhoogt zoals ook het geval is tijdens koorts. Proefpersonen in dit hoofdstuk 
voeren driemaal identieke inspanning uit op een loopband waarbij ze voorafgaand aan de 
inspanning medicatie slikken die de prostaglandine E
2
 productie (een van de belangrijkste 
mediatoren die het setpoint verhogen) blokkeert op centraal en perifeer niveau, op alleen 
centraal niveau of helemaal niet blokkeert. Wanneer zowel centrale als perifere blokkade 
van de prostaglandine productie plaats vindt blijkt de maximale kerntemperatuur 
tijdens inspanning significant lager te liggen vergeleken met de controle conditie (geen 
blokkade). Deze bevinding suggereert dat een verhoogd temperatuur setpoint deels 
verantwoordelijk zou kunnen zijn voor de stijging in kerntemperatuur tijdens inspanning.
Hoofdstuk 5 omvat een pilot studie gericht op het onderzoeken of er verschillen in 
thermoregulatoire reacties zijn tussen elite rolstoeltennissers met en zonder dwarslaesie. In 
totaal acht vrijwilligers (waarvan 3 met een dwarslaesie en 5 zonder dwarslaesie) speelden 
een 45-minuten durende rolstoeltennis wedstrijd terwijl verschillende thermoregulatoire 
parameters continue gemeten werden, waaronder kerntemperatuur en huidtemperatuur. 
Het belangrijkste resultaat laat zien dat de rolstoeltennissers met dwarslaesie een sterkere 
stijging van de kerntemperatuur lieten zien dan de rolstoeltennissers zonder dwarslaesie, 
hoewel deze data door een te kleine steekproef niet op significantie getoetst kon 
worden. Deze beschrijvende data suggereren dat rolstoeltennissers met een dwarslaesie 
mogelijk een verhoogd risico hebben op het ontwikkelen van hittegerelateerde 
gezondheidsproblematiek. Deze resultaten maken vervolgonderzoek om deze relatie 
verder te exploreren noodzakelijk.
Hoofdstuk 6 richt zich op de potentiële effecten van een verhoogde kerntemperatuur 
op het stollingssysteem. De stollingsactiviteit wordt bepaald in plasma monsters 
welke verkregen zijn direct voorafgaand aan en na afloop van het lopen van een 15-
km hardloopwedstrijd. De belangrijkste bevindingen tonen dat fysieke inspanning 
een verhoogde stollingsactiviteit veroorzaakt, welke mogelijk deels veroorzaakt wordt 
door de verhoogde kerntemperatuur tijdens inspanning. Wanneer de temperatuur 
van de stollingsassay zodanig wordt aangepast dat deze de kerntemperatuur van de 
proefpersoon tijdens bloedafname benadert (deze ligt vaak hoger dan de 37 C waar 
vanuit wordt gegaan bij de assay), dan blijkt de verhoogde stollingsactiviteit aanzienlijk 
meer uitgesproken te zijn na inspanning. Deze bevindingen tonen dat de bloedstolling 
wordt beïnvloed door de inspanningsgebonden stijging van de kerntemperatuur, maar 
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toont bovendien het belang aan van het synchroniseren van de assay temperatuur met 
de daadwerkelijke kerntemperatuur van de proefpersoon ten tijde van bloedafname.
Hoofdstuk 7 geeft een samenvatting van de belangrijkste bevindingen van dit 
proefschrift, en bediscussieert deze. Tevens wordt gepoogd een toekomstperspectief te 
schetsen van de individuele voorspelbaarheid en monitoring van de kerntemperatuur. 
Bovendien worden de klinische implicaties van de bevindingen bediscussieerd.
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Hoewel ik in dit proefschrift met de eer mag strijken, zijn alle studies in dit werk 
natuurlijk tot stand gekomen dankzij de inzet van velen. Zonder iemand tekort te willen 
doen, wil ik graag een aantal mensen wie een bijzondere rol hebben gespeeld in mijn 
onderzoeksperiode specifiek benoemen.
Mijn meeste dank en bewondering gaan uiteraard uit naar alle proefpersonen, wie 
vrijwillig, met veel enthousiasme en zonder enig eigenbelang alle metingen en 
vragenlijsten doorstonden, voorafgaand en na afloop van een op zich alleen al bijzondere 
hardloopprestatie. Ook wil ik de Stichting Zevenheuvelenloop, in het bijzonder Joan Merx 
en Ronald Veerbeek, hartelijk danken voor de enorme inzet die jullie alle jaren hebben 
getoond in het benaderen van proefpersonen en alle logistieke hulp.
Maria, al in het eerste jaar van mijn Geneeskunde opleiding kwamen wij in contact. Eerst 
als vrijwilliger bij de eerste editie van het Vierdaagse onderzoek, en het jaar erop was ik al 
welkom om als student tijdens de zomervakantie een kleine onderzoeksstage te komen 
doen. Elk jaar breidden we mijn betrokkenheid bij het Vierdaagse onderzoek en het 
Zevenheuvelenloop onderzoek verder uit, en al snel werd ik onderdeel van het meubilair. 
Ik was altijd welkom om mee te helpen, en hier profiteerden wij allebei van. Nog steeds 
ben ik erg jaloers op jouw eindeloze nieuwsgierigheid, interesse, manier van out-of-the-
box denken, en op jouw open houding. We waren het lang niet altijd met elkaar eens, 
en dit heeft nogal eens tot stevige discussies en impasses geleid. Maar nooit was jouw 
wil wet; het sterkste argument won altijd. Maria, dank voor alle kansen die je me hebt 
gegeven, dank voor al jouw wijsheden, kritische noten en de mooie onderzoeksjaren dit 
ik in grote zelfstandigheid op jouw afdeling heb mogen beleven.
Thijs, van alle mensen heb jij de grootste rol binnen mijn wetenschappelijke ontwikkeling 
en zeker ook binnen dit proefschrift gespeeld. Geen vraag was te gek, alles kon en mocht, 
en ook als iets niet kon verzon jij wel een of andere manier waarop het toch mogelijk 
werd. Met verbazing aanschouwde ik soms hoe jij met je gladde verkooppraatjes deuren 
opende waarvan ik niet eens wist dat er überhaupt een deur was. Zoals alleen maar een 
echte docent dat kan heb je mij en vele anderen altijd enorm weten te enthousiasmeren 
voor het doen van nieuwe studies, analyses en het schrijven van nieuwe artikelen. Met 
veel bewondering volg ik nog steeds de wijze waarop je in rap tempo uitgroeit tot een 
van de topwetenschappers die ons land te bieden heeft. Thijs, ik heb enorm veel van je 
geleerd en genoten van onze bijzonder fijne samenwerking. Ik hoop dat ik zo nu en dan 
nog eens op je expertise mag terugvallen. Thijs, heel erg bedankt.
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Dick, hoewel jij je doorgaans op de achtergrond probeert te houden is jouw rol binnen 
mijn promotie niet klein geweest. Je kennis en inzicht over alle mogelijke onderwerpen 
binnen ons gebied van de wetenschap is onbeschrijflijk, en je hebt dit altijd precies weten 
te gebruiken om weer een mooi artikel of CMO aanvraag de deur uit te sturen. De wijze 
waarop jij 16 uur per dag opperste concentratie weet te behouden tussen je taken als 
vader door is inspirerend. Dank voor jouw bijdrage aan mijn proefschrift en aan mijn 
wetenschappelijke ontwikkeling.
Leonie, als kamergenootjes hebben wij altijd bijzonder goed onze frustraties kunnen delen 
over alles wat er op wetenschappelijk en persoonlijk gebied mis is met de wereld. Ik heb altijd 
erg genoten van onze eindeloze gesprekken over de meest diverse onderwerpen – uiteraard 
nooit in de baas haar tijd. Dank je dat jij alles uiteindelijk weer relativeerde tot een “komt wel 
goed” en dank voor de nuchtere blikken, humor en gezelligheid die jij in onze kamer bracht. 
Nathalie, jij bracht al stuiterend over de afdeling altijd wat extra leven in de brouwerij. 
Niemand die alles zo goed tot in de puntjes had uitgezocht en haar zaakjes zo goed op orde 
had als jij. Wij konden altijd bij elkaar terecht voor advies op medisch en wetenschappelijk 
vlak, maar jij was ook altijd in voor het organiseren van de gezellige momenten tijdens en na 
het werk. Bedankt hiervoor. Jean, nog nooit heb ik iemand ontmoet die zo’n goed hart heeft 
als jij. Jouw harde werkmentaliteit maar in het bijzonder de manier waarop jij iedereen met 
zoveel goedheid en respect weet te behandelen, heb ik altijd enorm bewonderd. Bedankt 
dat ik van jouw kwaliteiten als wetenschapper, maar nog belangrijker als mens, heb mogen 
leren. Tim, van ‘hertjes spotten’ tot het uitzoeken van de beste playlist; jij wist de kamer 
altijd tot een nieuw episch niveau te brengen. Onder je verschijning als grappenmaker en 
gangmaker ken ik je ook als iemand met grote integriteit, en een nauwkeurig en een harde 
werker. Van jou heb ik ook veel mogen leren, dank daarvoor. Joost, hoe jij het al die tijd voor 
elkaar hebt gekregen je vele taken als vader, leraar, fysiotherapeut, voetballer, onderzoeker 
én gewoon als mens te combineren is me volstrekt onduidelijk. Ik heb groot respect voor 
je. Coen, ook jou ken ik sinds je voor het eerst als student bij ons op de afdeling kwam. Ik 
heb je nog nooit langzaam zien werken, je hebt altijd grote inhoudelijke kennis en inzicht 
laten zien binnen jouw vakgebied, en we konden altijd prettig overleggen als één van ons 
vast zat met een analyse of resultaten. Je gaat een prachtig proefschrift tegemoet, en ik 
ben zeer benieuwd naar je vervolg als onderzoeker. Bregina, op jou heb ik altijd mogen 
rekenen voor ondersteuning in de breedste zin. Dank je wel dat je altijd klaar stond om 
te helpen. Piet, bij jou kon ik altijd terecht voor een kritische blik en vooral wijsheid over 
de meest uiteenlopende onderwerpen. Bedankt dat je dit altijd hebt willen delen. Linda, 
voordat je vertrok van onze afdeling kon ik altijd bij je terecht voor logistieke zaken, bedankt 
hiervoor. Femke, jij was altijd het zonnetje van de afdeling. Dank voor jouw verschijning in 
het algemeen, en dank voor je gezelligheid als zaken weer even tegenzaten.
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Dineke, al tijdens jouw stage liet je bovengemiddelde betrokkenheid en inzet zien. Dankzij 
jouw aanhoudende inzet en enthousiasme bij ‘onze’ studie ook na je vertrek ligt er nu een 
prachtig artikel. Inmiddels ben je in opleiding tot sportarts, iets waar je ongetwijfeld in 
zult uitblinken.
Martijn, wij leerden elkaar kennen toen jij nog als student rondliep op onze afdeling. Echt 
student was je eigenlijk niet, want al vanaf het begin was het iedereen duidelijk dat we snel 
collega’s zouden worden. Jouw grote statistische kennis kwam mij meer dan eens goed 
van pas, en onze ‘spar’ sessies waarin we ideeën wisselden over de analyse en interpretatie 
van onze studies heb ik altijd bijzonder goed gewaardeerd. Bovenal waardeer ik onze 
interesse in fotografie en onze vriendschap het meest, en ben ik blij dat jij ook nog wel 
eens aan mij vraagt: “hoe heb je dat gedaan?” in plaats van alleen andersom.
Bart, al sinds onze eerste kennismaking in de derde maand van onze geneeskundeopleiding 
kennen wij elkaar. Al vanaf het begin bleef jij mij uitdagen om te begrijpen hoe dingen 
werken, en nog vaker legde je het me daarna zelf uit. Dat je nog energie over hield voor 
dat soort analyses terwijl je tegelijkertijd zowel geneeskunde als natuurkunde studeerde 
is mij nog steeds een raadsel. Laten we vooral nog lang doorgaan met deze analyses terwijl 
jij jouw promotie afrondt. En laten we zeker ook onze traditionele bioscoop bezoeken niet 
vergeten erin te houden.
Alexandra en Ilse, jullie hebben me altijd op de been gehouden, onder andere met voedsel 
na een lange werkdag en het bij elkaar vegen van wat ‘mentale scherven’ wanneer het 
leek alsof mijn proefschrift nooit voltooid zou worden. Bedankt voor jullie steun om dit 
proefschrift tot een mooi einde te brengen.
Fatima, your support to finish my thesis has been unmissable. You provided me an 
environment to keep writing when I was stuck, and used your incredible knowledge 
about business and presentation to help me improve chapters and figures even though 
you only had a basic conceptual understanding of what I was trying to do. It takes a great 
mind to do so. Life will bring you very far if you keep living by your own rules. Thank you.
Pap, Wim, je hebt altijd je best gedaan zo goed mogelijk te begrijpen wat mijn werk 
precies inhield. En je vond het prachtig alle verhalen te horen waar ik weer mee thuis 
kwam. Jouw enthousiasme gaf me altijd weer dat extra zetje om door te gaan. Helaas 
heeft het niet meer zo mogen zijn dat je bij mijn promotie aanwezig bent, maar dat je erg 
trots was toen mijn proefschrift voltooid was, was me heel duidelijk. Bedankt voor al je 
steun door de jaren heen. Moeders, Wilma, net als ons pa heb je altijd vooraan gestaan om 
al mijn verhalen te mogen aanhoren. Je hebt zelfs een keer meegeholpen bij het doen van 
metingen, en jullie hebben met zijn tweeën altijd gezorgd dat ik over alles beschikte wat 
ik nodig had. Bedankt voor je onmisbare steun. Mieke, je hebt altijd enorm hard gewerkt 
bij de diverse studies die je hebt gevolgd. Binnenkort studeer je af binnen de voeding en 
diëtetiek, en dan is het een kwestie van het vinden van een mooie baan. Jij komt er wel.
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Matthijs Veltmeijer werd op 26 januari 1988 geboren te UMC St. Radboud, Nijmegen. Na 
het Voorbereidend Wetenschappelijk Onderwijs op het Titus Brandsma College te Oss 
succesvol te hebben voltooid, startte hij in 2006 met de opleiding Geneeskunde aan de 
Radboud Universiteit Nijmegen. Tijdens zijn tweede studiejaar nam kwam hij voor het 
eerst in aanraking met wetenschappelijk onderzoek als lid van het Nijmeegse Vierdaagse 
onderzoeksteam. Het jaar erop volgde de eerste kleine wetenschappelijke stage op de 
afdeling Integratieve Fysiologie, en het volgende jaar een grote wetenschappelijke stage 
als onderdeel van de Master Geneeskunde. Ook tijdens zijn coschappen bleef Matthijs in 
de avond- en weekenduren betrokken bij het Vierdaagse maar ook Zevenheuvelenloop 
onderzoeksteam als Student Assistent en voerde diverse metingen en analyses uit in 
het kader van deze studies. Na afronding van zijn Geneeskunde studie in 2012 werden 
deze activiteiten voortgezet als fulltime promotieonderzoek. Na 2 jaar fulltime te hebben 
gewerkt als promovendus op de afdeling Fysiologie in het Radboudumc, vervolgde 
Matthijs zijn medische carrière als arts op de Spoedeisende Hulp en Eerste Hart Hulp 
in Gelre Ziekenhuizen Zutphen en later op de Spoedeisende Hulp in Viecuri Medisch 
Centrum Venlo.
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Aansluitend zal een receptie
plaatsvinden in de 
ondergelegen zaal.
Dit proefschrift richt zich op thermoregulatie tijdens hardlopen. Na het 
behandelen van de algemene principes van thermoregulatie tijdens inspanning 
wordt onderzocht hoe vaak hyperthermie (een kerntemperatuur hoger dan 
40°C) voorkomt na het lopen van een 15-km hardloopwedstrijd. Tevens worden 
factoren geïdenti ceerd die signi cant kunnen voorspellen in hoeverre de 
kerntemperatuur tijdens inspanning zal stijgen. In de opvolgende hoofdstukken 
wordt de rol onderzocht van afzonderlijke systemen die invloed hebben op, 
of beïnvloed worden door de kerntemperatuur tijdens inspanning. Allereerst 
wordt onderzocht in hoeverre pro-in ammatoire cytokines welke aangrijpen 
op het hypothalame temperatuursetpoint een rol spelen in de stijging van de 
kerntemperatuur tijdens inspanning. Voorts wordt in een beschrijvende pilotstudie 
onderzocht of elite rolstoeltennis atleten met een dwarslaesie een grotere kans 
hebben op warmte-gerelateerde gezondheidsproblemen vergeleken met elite 
rolstoeltennis atleten zonder dwarslaesie. Als laatste worden de potentiële 
e ecten van een verhoogde kerntemperatuur op het stollingssysteem beschreven.
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